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1.  INTRODUCTION 
 
 
Toxoplasmosis is caused by a coccidian protozoan parasite, 
Toxoplasma gondii. Humans and other warm-blooded animals are its 
intermediate hosts. The infection has a worldwide distribution. 
Approximately one-third of all humanity has been exposed to this 
parasite. Although usually asymptomatic in immunocompetent 
adults, it can cause severe disease manifestations and even death in 
immunocompromised patients. If acquired during pregnancy it can 
cause various congenital anomalies in the child.  
 
In India, the exact seroprevalence of this infection is not known. 
However, using various diagnostic tests, the prevalence has been 
reported to be as low as 1 per cent and as high as 80 per cent in 
adults (Singh, 2003). There is lack of awareness and knowledge about 
this zoonotic infection.  
 
Asymptomatic toxoplasmosis is the commonest type despite the 
“Sea of toxoplasmosis infection around us”. Feline species especially 
cat is the “Key host” for toxoplasmosis and most of the animals, birds 
including human beings are acting as an intermediate host. Although 
toxoplasmosis infects large proportion of world’s human populations, 
it is thought to be an uncommon cause of typical disease in early 
days. Nowadays, certain individuals however are at high risk for 
severe or life threatening disease due to this parasite.  
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Humans are infected either through contaminated food, water, 
transfusion of infected blood, organ transplantation and from mother 
to foetus through placenta. Congenital toxoplasmosis is the result of 
maternal infection acquired during gestation, an infection that is most 
often clinically inapparent. In immunodeficient patients, 
toxoplasmosis most often occurs in person with defects in T cell 
mediated immunity such as those with haematologic malignancies, 
bone marrow and solid organ transplant recipients or acquired 
immunodeficiency syndrome (AIDS). In immunocompetent individual, 
after acute infection a small percentage suffer chorioretinitis, 
lymphadenitis, encephalitis or even more rarely, myocarditis and 
polymyositis.  
 
The prevalence of toxoplasmosis in Indian pregnant women is 
variably reported (Singh, 2003 and Singh and Pandit, 2004). However, 
the knowledge about this infection, diagnosis and interpretation of the 
test results is a major problem in the Indian context. Though, 
Toxoplasma infection does not cause repeated foetal losses, this is the 
most common indication for investigation of toxoplasmosis in India.  
 
There are several diagnostic test kits available in Indian 
markets, however, their qualities is not assessed by most of the 
laboratories before they are procured (Singh et al., 1997). There is no 
baseline data on seroprevalence and antibody titres of toxoplasmosis 
in various subpopulations in different parts of our country. There is a 
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lack of awareness and knowledge about this zoonotic infection. 
Further complicating the situation, there are several commercial 
organisations that are promoting their products without proper 
background knowledge and base line data from India.  
 
Under this situation, it is highly imperative to assess the status 
of seroprevalence of toxoplasmosis in Tamil Nadu especially in 
pregnant women and immunodeficient patients based on suitable IgG 
based ‘in-house’ immunoassays like IFAT, ELISA and MAT, using 
laboratory prepared own antigen and known positive serum.  
 
Perusal of available literature revealed no systematic studies on 
seroprevalence of toxoplasmosis in humans in southern parts of  
Tamil Nadu was undertaken. The study was aimed to bring out status 
of toxoplasmosis in southern districts of Tamil Nadu and possibly 
evaluation of different serodiagnostic methods for diagnosis of 
toxoplasmosis especially in pregnant women and immunodeficient 
patients.   
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2.  AIM AND OBJECTIVES 
                                        
  The study was designed with the following objectives 
 
 To find out the seroprevalence of toxoplasmosis in           
immunodeficient patients (HIV and malignant patients) 
and immunocompetent patients like pregnant women, 
ocular chorioretinitis cases and patients with 
lymphadenopathy in and around Tirunelveli district of 
Tamil Nadu. 
 
 To evaluate the IgG based tests like Modified direct 
Agglutination Test (MAT), Indirect Fluorescent Antibody 
Test (IFAT) and Enzyme Linked Immunosorbent Assay 
(ELISA) for serodiagnosis of toxoplasmosis. 
 
 To compare the utility of the IgG based tests like MAT, 
IFAT and ELISA for its suitability of the strategy for 
serodiagnosis and interpretation of toxoplasmosis. 
 
 To compare the CD4+/CD8+ count of T lymphocytes in 
HIV patients of seropositive and seronegative group of 
toxoplasmosis.   
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3. REVIEW OF LITERATURE 
 
 
 Toxoplasmosis, an important protozoan parasitic disease is 
caused by Toxoplasma gondii the single species of genus, Toxoplasma. 
It is generally a self-limited, asymptomatic illness in 
immunocompetent patients, although infection can reactivate at a 
later time if the patient becomes immunosuppressed. Primary 
maternal infection during pregnancy can be transmitted to the fetus 
and result in serious sequelae.  
 
3.1  HISTORY  
 
T. gondii was first observed by Charles Nicolle and Louis 
Manceaux in 1908 in North African rodent, gundi (Ctenodactylus 
gundi) at the Pasteur institute, Tunis. At the same time, 1908 Alfonso 
Splendore described it from a laboratory rabbit at the Portuguese 
hospital in Sao Paulo, Brazil. In 1923, Janku, an ophthalmologist in 
Praque reported it in an 11 month old congenitally infected child. In 
1939, Wolf, Cowen and Paige reported a confirmed case of congenital 
case of toxoplasmosis in a child. Vietzke et al. in 1968 reported several 
severe and potentially fatal disease of Toxoplasma encephalitis in 
patients with hematologic cancers. The complete life cycle of it was not 
determined until 1970 by Frenkel, Dubey, and Miller.  It then became 
more widely recorded as a cause of morbidity in immunodeficient 
patients, including AIDS patients beginning in 1983. T. gondii 
continues to be an important disease in the modern world, especially 
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in pregnant women and immunocompromised patients. The brief 
review of historical landmarks of T. gondii discovery is presented in 
Table 1. (Dubey, 1993) 
 
3.2  TAXONOMY  
 
Toxoplasma belongs to the protozoan Phylum Apicomplexa 
Levine, 1970 which consists of intracellular parasites that have a 
characteristically polarized cell structure and a complex cytoskeletal 
and organellar arrangement at their apical end (Plate 1).  T. gondii 
classified as a heteroxenous or two-host coccidian, forming tissue 
cysts. It is grouped in the Subfamily Toxoplasmatinae, Family 
Sarcosystidae Pouche, 1913, Suborder Eimeriorina, Order 
Eucoccidiorida, Subclass Coccidiasina, Class Sporozoasida of Phylum 
Apicomplexa.  
 
Opinions differ regarding the placement of T. gondii into families 
and subfamilies. Various authorities have placed it in one or other of 
the families Eimeriidae Michin, 1903; Sarcocystidae Poche, 1913, or 
Toxoplasmatidae Biocca, 1956. At present the T. gondii is the only 
species assigned to the genus Toxoplasma. Taxonomic position 
commonly followed by most of the author is depicted in the Table 2. 
 
3.3  MORPHOLOGICAL STAGES AND THE LIFECYCLE 
 
There are three infectious stages of T. gondii; the tachyzoites (in 
groups or clones), the bradyzoites (in tissue cysts), and the sporozoites 
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(in oocysts). These stages are linked in a complex life cycle (Dubey  
et al., 1998). (Plate 2) 
 
3.3.1 Tachyzoite   
 
The term "tachyzoite" (tachos = speed in Greek) was coined by 
Frenkel (1973) to describe the stage that rapidly multiplied in any cell 
of the intermediate host and in non-intestinal epithelial cells of the 
definitive host. The term "tachyzoite" replaces the previously used term 
"trophozoite" (trophicos = feeding in Greek). Tachyzoites have also been 
termed endodyozoites or endozoites. Aggregates of numerous 
tachyzoites are called clones, terminal colonies, or groups. 
 
Tachyzoites (Plate 3.1) have also been termed endodyozoites or 
endozoites. Aggregates of numerous tachyzoites are called clones, 
terminal colonies or groups. The tachyzoite is often crescent shaped, 
approximately 2 - 4 by 4 - 8 µm with a pointed anterior (conoidal) end 
and a rounded posterior end with nucleus at the centre. 
 
3.3.2 Bradyzoite and Tissue cyst   
 
The term "bradyzoite" (brady = slow in Greek) was also coined 
by Frenkel (1973) to describe the organism multiplying slowly within a 
tissue cyst (Plate 3.2). Bradyzoites are also called cystozoites.  
 
Tissue cysts grow and remain intracellular as the bradyzoites 
divide by endodyogeny. Tissue cysts in the brain are often spheroidal 
and rarely reach a diameter of 70 µm, whereas intramuscular cysts 
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are elongated and may be 100 µm (Dubey, 1977). Although tissue 
cysts may develop in visceral organs, including the lungs, liver, and 
kidneys, they are more prevalent in the neural and muscular tissues, 
including the brain, eyes, and skeletal and cardiac muscles. Intact 
tissue cysts probably do not cause any harm and can persist for the 
life of the host without causing a host inflammatory response. The 
tissue cyst wall is elastic and thin (<0.5 µm thick) and it encloses 
hundreds of crescent-shaped bradyzoites each approximately 7 by 1.5 
µm in size. The tissue cyst develops within the host cell cytoplasm 
(Dubey, 1988a). 
3.3.4 Oocysts 
 
Unsporulated oocysts are sub spherical to spherical and are 10 
by 12 µm in diameter. Under light microscopy, the oocyst wall 
consists of two colorless layers. Polar granules are absent, and the 
sporont almost fills the oocyst. Sporulation occurs outside the cat 
within 1 to 5 days of excretion depending upon aeration and 
temperature.  
 
Sporulated oocysts (Plate 3.3) are sub spherical to ellipsoidal 
and are 11 by 13 µm in diameter. Each oocyst contains two ellipsoidal 
sporocysts without Stieda bodies. Sporocysts measure 6 by 8 µm. A 
sporocyst residuum is present; there is no oocyst residuum. Each 
sporocyst contains four sporozoites (Ferguson et al., 1978).  
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3.4    EPIDEMIOLOGY OF TOXOPLASMOSIS 
3.4.1  TRANSMISSION  
 
T. gondii is transmitted to humans by three principal routes 
(Desmonts et al., 1974; Dubey, 1998 and Jeffery et al., 2003).   
 
First, humans can acquire T. gondii by eating raw or 
inadequately cooked infected meat, especially pork, mutton, and wild 
game, or uncooked foods that have come in contact with infected 
meat.  
 
Second, humans can inadvertently ingest oocysts that cats have 
passed in their feces, either from a litter box or from soil (e.g., soil 
from gardening, on unwashed fruits or vegetables, or in unfiltered 
water).  
 
Third, women can transmit the infection transplacentally to 
their unborn fetus. In adults, the incubation period for T. gondii 
infection ranges from 10 to 23 days after the ingestion of undercooked 
meat and from five to 20 days after the ingestion of oocysts from cat 
feces.  
 
A report from the Economic Research Service of the U.S. 
Department of Agriculture concluded that one half of toxoplasmosis 
cases in the United States are caused by eating contaminated meat 
(Buzby and Roberts, 1996). This conclusion is supported by the 
findings of a community-based epidemiologic study (Roghmann et al., 
1999).  
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Women infected with T. gondii before conception rarely transmit 
the parasite to their fetus, but those who become acutely infected or 
have reactivation of T. gondii during pregnancy (i.e., because of 
immunosuppression) can transmit the organism transplacentally. The 
risk of congenital disease is lowest (10 to 25 per cent) when maternal 
infection occurs during the first trimester and highest (60 to 90  
per cent) when maternal infection occurs during the third trimester 
(Dunn et al., 1999).  
 
However, congenital disease is more severe when infection is 
acquired in the first trimester. The overall risk of congenital infection 
from acute T. gondii infection during pregnancy ranges from 
approximately 20 to 50 per cent. Immunosuppression resulting from 
human immunodeficiency virus (HIV) infection or therapies for 
malignancies, organ transplantation and lymphoproliferative disorders 
can result in the reactivation of latent T. gondii infection. Reactivation 
most often involves the CNS, and symptoms may include those of 
meningoencephalitis or a mass lesion. Women with reactivated  
T. gondii infection can transmit the organism transplacentally 
(Remington et al., 2001). 
 
The other miscellaneous modes of transmission of this parasite 
is also by transplantation of organs and transfusion of blood (Wreghitt 
et al.,1989; Singh et al., 1994; Slavin et al., 1994).  
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3.4.2  RISK FACTORS AND SOURCES OF INFECTION OF 
TOXOPLASMOSIS FOR HUMAN BEINGS 
 
3.4.2.1 Vegetarian and non-vegetarian  
   
Little is known of the sources for T. gondii infection for humans 
in India. Rawal (1959) found that the prevalence of T. gondii in 
vegetarians (37.8 per cent of 141) and non-vegetarians (37.4 per cent 
of 246) was similar.  Akoijam et al. (2002) carried out a study in rural 
area near Delhi on primigravida women but could not find any 
significant difference between vegetarians and non-vegetarians. Also 
no difference was found on statistical analysis between women who 
had contact with cat and who did not have. The overall prevalence as 
measured by IgG antibodies was 41.2 per cent.  
 
3.4.2.2 Undercooked meat 
 
Epidemiologic studies from other parts of world indicate that the 
ingestion of undercooked meat is an important means of transmission 
of T. gondii. For example, the very high (70 to 90 per cent) 
seroprevalence of T. gondii in Paris, France is attributed to eating 
undercooked meat (Dubey, 1988b).  
 
Traditionally, meat is cooked well before human consumption in 
India. T. gondii is killed when the internal temperature of the meat 
reaches 66°C. However, the recent introduction of fast food chain 
restaurants in India might change this situation. T. gondii may survive 
in improperly grilled or barbecued meat. Such an outbreak did occur 
in a group of medical students in New York City who ate hamburgers 
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(presumably contaminated with meat from other animals) which were 
undercooked. Toxoplasma gondii is also killed by freezing; freezing in a 
household freezer for one day is generally sufficient to kill this 
parasite in meat (Dubey, 1988b). 
 
 Poor hygiene observed in India during handling of meat from 
slaughter house to kitchen can be a source of T. gondii infection 
(Singh and Singh, 1994 & Singh et al., 1996). Although no data are 
available on the consumption of undercooked meat in India, the 
prevalence of Sarcocystis suihominis oocysts in faeces of 14 of 20 
children indicates that meat was consumed raw at least by some 
because S. suihominis can only be transmitted to humans by the 
consumption of raw pork (Banerjee, 1994).  
                                                                                                                   
  
3.4.3  SEROPREVALENCE OF TOXOPLASMOSIS  
 
3.4.3.1 Seroprevalence of toxoplasmosis in India 
 
 Until recently the prevalence of T. gondii in the general 
population of India was considered to be low compared with Western 
countries (Bowerman, 1991 and Mittal et al., 1995). This may be 
partially true, but the data are based on convenience samples 
obtained from patients admitted to hospitals in big cities. The type of 
serological tests used and the titres taken as evidence of infection are 
also important factors. Because most of the population (75 per cent) of 
India lives in rural villages with little means to get to city hospitals, 
the data are not reflective of the population as a whole. Moreover, data 
 17
are based on low titres (1:64) in IHA Test, the specificity of which is 
doubtful. Three studies during 1990, however, indicate that the 
prevalence may be a lot higher than previously considered. (Singh and 
Nautiyal, 1991 and Singh et al., 1994a)  
 
Bhatia et al. (1974) performed a serological study of 
Toxoplasmosis in South India and noted IgM antibodies by IHA were 
found in 12 per cent patients.   
 
A study done in Delhi at National Institute of Communicable 
Diseases by Mittal et al. (1990), revealed an overall seroprevalence of 
only 1 per cent in the 200 samples studied from the general 
population.  
 
In another survey of 100 asymptomatic women (83 of them 16-
50 years old) from villages in Almora district, 57 per cent had IHA 
antibodies in titres of 162 or more (20 of them had titres of 18 to 54). 
Even if one discounted lower IHA titres as nonspecific, this is a high 
prevalence of T. gondii in women of child bearing age, ever reported 
earlier from any part of India (Singh and Nautiyal, 1991). 
 
Banerjee et al., (1994) surveyed 27 villages surrounding a 
hospital in Kulapur, UP. Of the 123 serum samples obtained, 18  
per cent had IHA antibodies to T. gondii at a titre of 1:64. Prevalence 
increased with age. Of importance is that four of 41 (10 per cent) 
children below nine years of age were seropositive suggesting exposure 
to contaminated food or congenital infection. 
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In another study of children from a residential tribal school in 
Maharashtra, 35.1 per cent of 194 persons had T. gondii antibodies. 
Of particular interest 30 per cent prevalence rate was noticed in 10 to 
12 year old children and IgG positivity in 75 per cent adult food 
handlers of the school mess (Singh et al., 1994b). 
 
Shanmugam et al. (1995) studied the Toxoplasma gondii IgM 
antibody prevalence in patients suffering from neurological disorders 
in Trivandrum, Kerala by ELISA. The study revealed high prevalence 
rate of toxoplasmosis in neurosurgery patients (32.7 per cent) and in 
particular among female (35.2 per cent) than male (17.8 per cent) 
patients. 
 
Mahajan (1997) reviewed the seroprevalence of toxoplasmosis in 
different parts of India which is presented in Table 3.  
 
Meisheri et al. (1997) conducted a study of seroprevalence of 
Toxoplasmosis in general population and in HIV/AIDS patients in 
Bombay and reported the overall seroprevalence was 30.9 per cent 
(51/165) in the immunocompetent adult (34 per cent in men and 26.2 
per cent in women). In HIV infected hosts the seroprevalence was 67.8 
per cent.  
 
Sharma et al. (1997) reported a significant increase in 
seropositivity in women and newborns) in Chandigarh was seen 
during 1989-91 as compared to 1981-88. More seropositive patients 
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were recorded between April-June and October-December. However, 
no significant correlation could be observed between rising incidence 
of seropositivity and the seasonal distribution or age of women. 
Toxoplasma seropositivity remained constant at 0.02 per cent from 
1981 to 1987; this rate increased to 0.06 per cent in 1989, 0.08 per 
cent in 1990, and 0.15 per cent in 1991. 
 
Joshi et al. (1998) carried out the seroprevalence of 
toxoplasmosis in Jodhpur. Toxoplasma gondii specific IgG and IgM 
antibodies were assayed by ELISA and seropositivity to one or both 
classes of antibodies was observed in 17.2 per cent cases. 
 
Akoijam et al. (2002) performed a study among primigravid 
women attending a secondary level hospital in a district of North India 
using IgG ELISA and reported 41.75 per cent were seropositive for 
Toxoplasma gondii infection.  
 
Mohan et al. (2002) carried out the ELISA based 
seroepidemiological study of toxoplasmosis in different sections of 
population of Union Territory of Chandigarh and reported overall 
prevalence of 5.4 and 4.66 per cent, IgM and IgG anti-Toxoplasma 
antibodies respectively. Amongst, significantly higher number of 
people in slum area (7.8 per cent) showed IgM antibodies as compared 
to urban and rural areas (4.2 per cent each). 
 
Singh (2002) carried out the seroprevalence study, which was 
directly proportional to the age of population tested, with highest 
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prevalence of 77 per cent by the age of marriage (17-20 years). It was 
also indicated that prevalence and incidence of any of these infections 
are inversely correlated. 
 
A prospective study conducted by Singh and Pandit (2004) on 
incidence and prevalence of toxoplasmosis in Indian pregnant women 
indicated that the overall IgG seroprevalence rate of toxoplasmosis 
was 45 per cent. Only seven women (3.3 per cent) were found to have 
IgM antibodies and only two of these showed low IgG avidity indicating 
recent infection of ≤4 months duration. One woman aborted 
spontaneously at her fourth month of gestation. In remaining five 
women the recent infection could successfully be excluded by IgG 
avidity testing. All these women had uneventful pregnancy. 
Yasodhara et al. (2004) from Hyderabad, South India reported 
toxoplasmosis seroprevalence of 33 per cent (IgG) in lower 
socioeconomic group compared to higher socio-economic group (22 
per cent) in 236 women with bad obstetric history.  
Naveen et al. (2005) studied TORCH infection in 20 pregnant 
women with bad obstetric history in Kumaon region and revealed 
ELISA IgM and IgG antibodies for Toxoplasma were found in 20 and 
55 per cent of patients respectively.  
 
Manikandan et al. (2006) recently reported an outbreak of 
ocular toxoplasmosis in Coimbatore, Tamil Nadu, which was an acute 
acquired type through municipal water contamination. Out of 249 
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cases tested during the outbreak, 178 cases reported to had high 
titres of both IgM and IgG antibodies and 4 cases showed presence of 
IgM antibodies alone. Although all age groups were affected but a 
majority of them were above 20 years of age.  
 
Rajendra et al. (2006) evaluated the incidence of TORCH 
infections in pregnancy wastage in women with bad obstetric history 
and noted 14.66 per cent, were seropositivity for Toxoplasma IgG. IgM 
antibodies were found in 27.27 per cent of cases with recurrent 
abortions.  
 
Sundar et al. (2007) performed the seroprevalence of 
Toxoplasma gondii in 1,000 healthy adult population of voluntary 
blood donors in Karnataka, South India by ELISA and reported the 
overall prevalence of 20.3 per cent were positive for T. gondii IgG 
antibody, of which, 63 per cent had high and 7 per cent low avidity 
and 3.6 per cent IgM positive. 
 
3.4.3.2 Seroprevalence of toxoplasmosis in other countries 
 
Seroprevalence of toxoplasmosis studies vary according to 
geographic location. The global seroprevalence was reported to be 46.1 
per cent (Jacquire, 1995). The incidence of primary Toxoplasma 
infection was reported as 1.1/1,000 pregnancies. In this study it was 
slightly higher than the earlier reports from USA where, rate of 
primary Toxoplasma infection was <1/1000 pregnancies (Lamb et al., 
1968; Dubey, 1988 and Remington et al., 1995) 
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A study by Jones et al. (1996) in 9 United States (US) cities 
found that Toxoplasma encephalitis in HIV-infected person varied by 
geographic area. About 10-40 per cent of adults with AIDS were 
seropositive for Toxoplasmosis in US. In Europe, Latin America and 
Africa where the incidence of latent Toxoplasma infection was between 
75-90 per cent, number of AIDS patients who developed toxoplasmic 
encephalitis may be 3-4 times higher than in US (Raffi, et al., 1997).  
 
In a study from a Scandinavian country, incidence of 
Toxoplasma gondii infections in 3,094 Swedish women during 
pregnancy was performed during 1992-93. Specific IgG anti-
Toxoplasma antibodies were found in 14 per cent (450/3,094) 
(Evengard et al., 1999). 
 
Rey et al. (1999) carried out a serological survey of Toxoplasma 
gondii infection in population groups in Fortaleza, Brazil. Out of 997 
persons, 22.8 per cent of children (mean age 3 to 8 years), 58.4 per 
cent of students (mean 11.4 years) and 71.5 per cent of pregnant and 
postpartum women (mean 24 years), were seropositives (p < 0.001). 
They concluded that the toxoplasmosis seroprevalence showed a rapid 
increase during the first ten years of life, in association with close 
contact with cats and larger households, probably related to 
inappropriate hygiene and child-care practices. 
 
Falusi et al. (2002) assessed the prevalence and predictors of 
latent Toxoplasma infection in a large group of human 
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immunodeficiency virus (HIV)–infected and HIV-uninfected at-risk US 
women. The prevalence of latent Toxoplasma infection was 15 per cent 
(380 of 2525 persons) and did not differ by HIV infection status. HIV-
infected women aged ≥50 years and those born outside of the United 
States were more likely to have latent Toxoplasma infection, with 
prevalences of 32 per cent and 41 per cent, respectively.  
 
Nissapatorn et al. (2003) stated that the seroprevalence of 
toxoplasmosis among 406 AIDS patients was 208 (51.2 per cent) in 
the Hospital Kuala Lumpur (HKL), Malaysia. Their age ranged from 17 
to 74 years with a median of 35 years and the majority of patients 
were males 172 (82.6 per cent).  
 
Diza et al. (2005) estimated the seroprevalence of Toxoplasma 
gondii in the northern Greek population based on IgG-specific 
antibodies by IFA and found to be 37 per cent, 29.9 per cent and 24.1 
per cent in 1984, 1994 and 2004, respectively, and was 35.6 per cent, 
25.6 per cent and 20 per cent, respectively, in women of reproductive 
age (15–39 years). 
 
Sema et al. (2005) stated that the seroprevalence of anti-
Toxoplasma IgG antibodies for toxoplasmosis was 30.1 per cent 
among pregnant women in Aydin Province, Turkey. Seroprevalence 
was increased with age and with drinking water consumption other 
than bottled water.   
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Birgisdóttir et al. (2006) investigated the prevalence and risk 
factors for T. gondii infection in Iceland, Sweden and Estonia, from 
1277 randomly selected persons. The presence of T. gondii IgG 
antibodies was determined by an ELISA method and reported the 
prevalence of 54.9 per cent in Tartu, 23 per cent in Uppsala and 9.8 
per cent in Reykjavik in the above said countries respectively. 
 
Francisco et al. (2006) reported the seroprevalence for  
T. gondii in human population from Brazil might range from 40 to 80 
per cent. They analysed the seroprevalence of T. gondii infection in 
children from age one to 15 living in a low socioeconomic community, 
in Brazil and antibodies to T. gondii were found in 110 (32.4 per cent) 
of the 339 children tested with indirect immunofluorescent antibody 
test. 
 
Studeničová et al. (2006) conducted prospective, cross-sectional 
study to evaluate the seroprevalence of T. gondii antibodies in a non-
endemic area among 508 healthy individuals in Slovakia using ELISA 
to detect the levels of IgG, IgA, and IgM antibodies. IgG antibody 
prevalence of 24.2 per cent (123/508) was found in the study 
population, while examination of specific IgA and IgM antibodies was 
negative. They confirmed a significant increase in toxoplasmosis 
prevalence with increasing age.  
 
Jeffrey et al. (2007) determined the prevalence of T. gondii 
infection in U.S. Of the 17,672 persons examined in 1999–2004, 
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15,960 (90 per cent) were retested and reported that T. gondii 
seroprevalence declined from 14.1 per cent to 9.0 per cent among U.S. 
born persons of ages 12-49 years. Although T. gondii infects many 
persons in the U.S., the prevalence has declined in the past decade. 
  
3.5  DIAGNOSIS OF TOXOPLASMOSIS  
 
Toxoplasmosis in humans was usually diagnosed by biological, 
serological, histological, or molecular methods, or by some 
combination of the above. Clinical signs of toxoplasmosis were non-
specific and not sufficiently characteristic for a definite diagnosis. 
Toxoplasmosis in fact mimics several other infectious diseases.  
 
3.5.1  ISOLATION OF ORGANISM 
  
 Toxoplasma gondii was usually isolated from susceptible 
laboratory animals. Mice were most commonly used, since they can be 
readily infected by intraperitoneal injections of tachyzoites or 
bradyzoites. Depending on the virulence of the strain, mice will 
develop either an acute infection with parasite-rich ascites or a 
chronic infection characterized by the presence of cysts in the brain. 
Inoculation of blood, body fluids, or tissue extracts into mice may be 
used for diagnosis of acute condition (Jones et al., 1958 and Abbas, 
1967), but the result was often delayed because the encysted 
parasites may not be identified before 30 days after inoculation. 
 
Several reports demonstrated that tissue culture methods could 
be applied to the isolation of Toxoplasma organisms from blood or 
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infected tissues and served for diagnosis when serological tests were 
inconclusive. Tissue cell culture had the advantage of wide spread 
availability and yielded the result more rapidly within 3 to 6 days than 
mouse inoculation. However, mouse inoculation was more sensitive 
(Chang, et al., 1972; Hofflin and Remington, 1985 and Shepp, et al., 
1985). 
 
Francis et al. (1987) compared the mice inoculation method and 
tissue culture technique and reported that the course of infection in 
mice was greatly dependent on the virulence of the strain and on the 
parasitic stage inoculated. In the chronically infected mice, evidence of 
Toxoplasma infection was only detected 45 days after inoculation 
through the demonstration of cysts in the brain or the presence of 
specific antibodies in the serum. The tissue culture method was found 
to be at least as sensitive as mouse inoculation. Since Toxoplasma 
organisms may be isolated within a few days in tissue culture, it was 
proposed that this method should be used when early isolation of the 
parasite was crucial for the diagnosis of toxoplasmosis. 
 
3.5.2   SEROLOGICAL DIAGNOSIS  
 
The use of serological tests for the demonstration of specific 
antibody to T. gondii was the primary method of diagnosis. The 
problem with serologic diagnosis was that antibody to T. gondii was 
present in relatively high numbers of individuals in most human 
populations. These antibody titers may persist at high levels for years 
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even in healthy people. A large number of tests had been described, 
some of which were still in the experimental stage or were available 
only in highly specialized laboratories. Different serologic tests often 
measures different antibodies that possessed unique patterns of rise 
and fall with the time after infection. False-positive and false-negative 
results had been problem with certain commercial kits and 
laboratories in certain countries (Liesenfeld et al., 2001).  
 
There was no single serological test that can be used to support 
the diagnosis of acute or chronic infection of T. gondii. Numerous 
serological procedures called panel of T. gondii serologic profile (TSP) 
were available for the detection of humoral antibodies including the 
Sabin–Feldman dye test, the indirect haemagglutination assay (IHA), 
the indirect fluorescent antibody assay (IgG and IgM-IFA), the direct 
agglutination test (DAT or modified agglutination test (MAT), the latex 
agglutination test (LAT), the enzyme-linked immunosorbent assay 
(IgG, IgM, IgA, IgE-ELISA); the IgG Avidity test and the 
immunosorbent agglutination assay test (IgE and IgM-ISAGA) (Dubey, 
1998).  
 
                                                                                                                                    
3.5.2.1 INDIRECT FLUORESCENT ANTIBODY (IFA) TECHNIQUE  
 
The indirect fluorescent antibody (IFA) test measured the IgG 
antibodies as the dye test. Titers were parallel to dye test titers. The 
IgM fluorescent antibody test was used to detect IgM antibodies within 
the first week of infection, but titers fall within a few months. 
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The indirect fluorescent antibody technique was used to titrate 
patients' antibody against T. gondii. The reactions of the gamma 
globulin of human immune serum with T. gondii and fluorescent 
rabbit anti-human gamma globulin were thus shown to be specific. 
Thereafter the technique could be used with confidence to detect the 
reaction between doubling dilutions of patient's serum and smears of 
unfixed T. gondii. In this way, titres were obtained with the indirect 
fluorescent antibody technique which agreed well with those of the 
dye test at both low and high levels of antibody. Compared with the 
dye test, the indirect fluorescent antibody technique had many 
advantages. The end-point was sharp and obviates the counting of 
stained and unstained organisms; supplies of antibody-free accessory 
factor sera were not needed; prozones undetected by the dye test were 
strongly positive at screening dilutions, the reagents kept indefinitely 
and lend themselves to preparation, standardization, and issue by a 
central reference laboratory (Fletcher, 1965).  
 
Fausto et al. (1971) noted that in IFA tests false-positive results 
may occur with sera that contain antinuclear antibodies and false-
negative result may occur in sera with low IgG antibody titers. For this 
reason in patients with connective tissue disorders like systemic lupus 
erythematous, a DT or ELISA can be performed to document a positive 
result on IFA testing.  
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Sulzer et al. (1971) stated that to avoid misinterpretation of the 
polar staining of organism that was due to naturally occurring IgM 
antibodies, flurescein-tagged conjugate should be only anti-IgG.                                  
 
Shirley et al. (1982) compared ELISA and IFA tests, for detection 
of antibodies to T. gondii and reported that both the ELISA and the 
IFA correlated well with serologically positive (IFA titer 1:32) and 
negative sera. The ELISA was more specific, but less sensitive, than 
the IFA. However, the IFA was more reproducible and more rapid than 
the ELISA.  
 
Mittal et al. (1995) considered the titer of 1:64 or more were 
positive whereas most of recent authors such as Sema et al. (2005) 
and Cavalcante et al. (2006) taken dilutions of 1:16 and higher were 
as positive for IFAT. 
 
3.5.2.2 DIRECT AGGLUTINATION TEST (AG / DAT /MAT) 
 
The Toxoplasma agglutination (AG) test was first described by 
Fulton and Turk (1959). In this method whole killed organisms were 
used and it was routinely performed in France with an antigen that 
had been prepared as described by Ardoin, et al. (1967) and that was 
commercially available (BioMerieux, Charbonnieres-les-Bains, 
France). The method was very simple and useful but as presently used 
had two drawbacks. First, it lacks sensitivity; the titer in the AG test 
was usually much lower than that in the dye test (DT) or the 
conventional immunofluorescent-antibody (IFA) test. As a 
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consequence, some sera that were positive in the latter two tests were 
reported as negative in the AG test. Second, it lacks specificity; some 
sera that were negative in the DT and IFA test were reported as 
positive in the AG test (Couzineau, et al., 1973). This was shown to be 
due to the binding of normal immunoglobulin M (IgM) ("natural IgM 
antibody") to the surface of the parasite (Desmonts,  
et al , 1974 ). 
 
Desmonts and Remington (1980) described a method for 
preparing antigen which increases the sensitivity of the AG test and a 
method for suppressing nonspecific agglutination by the use of a 
buffer containing 2-mercaptoethanol (2ME). When the AG test was 
modified by these two methods, its specificity and sensitivity parallel 
those of the DT. The technique of modified agglutination test 
(MAT/MAGT) and the reading were so simple and accurate that, if the 
antigen was made available, the MAT method would be convenient for 
laboratories that perform serology only occasionally as well as for 
those that perform large-scale surveys. 
  
 Desmonts and Remington (1980) also concluded that the AG 
test titer was most often lower than the DT titer during acute (recent) 
infection and the AG test titer was most often higher than the DT titer 
in older or chronic infection. If the MAT test antigen using 2ME can be 
made available, the test would be ideal for use as a screening test and 
would provide a simple and inexpensive means for the surveillance of 
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seronegative women during pregnancy and for detection of 
seroconversions. 
 
Johnson et al. (1989) stated that AG test titers were usually 
markedly lower than those obtained with the DT or IFA test and that 
"negative" results were often obtained in DT-positive sera. For AG test 
doubling dilutions started from 1:20 and a positive direct 
agglutination test result was defined as that with titre of ≥ 40. 
  
Singh et al. (1996) modified the direct agglutination test 
described by Desmonts and Remington, 1980 and reported that 
antibody titers of 1:20 or more were taken as positive.  
 
Sema et al. (2005) considered titers of ≥ 20 were positive for the 
direct agglutination test using formalin fixed tachyzoites as antigen.  
 
3.5.2.3  ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
  
In the ELISA test the soluble antigen is absorbed on plastic 
surface and the antigen-antibody reaction is enhanced by the addition 
of secondary enzyme linked antibody- antigen system and the reaction 
can be assessed objectively by the quantitation of the colour that 
develops. ELISA is first described by Engvall and Perlmann in 1971 as 
a modification of the radioimmunosorbent technique (RIST), in which 
an enzyme is substituted for the radiolabel of the antiserum. Enzyme-
linked immunosorbent assay (ELISA) technology has largely replaced 
other methodologies in the routine clinical laboratory. It has been 
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used successfully to demonstrate IgG, IgM, IgA and IgE antibodies in 
the pregnant women, foetus and new born.  
 
Most workers have employed an enzyme-conjugated antibody 
directed against human IgG or against total immunoglobulins. Titers 
in the IgG ELISA correlated well with the titers in the DT, IHA, IFA, CF 
tests in some studies but not in others.  
 
IgM antibodies are measured by the "double-sandwich" or 
"immuno-capture" IgM-ELISA method. This method avoids false 
positive results due to the presence of rheumatoid factor and 
antinuclear antibodies. In patients with recently acquired infection, 
IgM T. gondii antibodies are detected initially and, in most cases, these 
titers become negative within a few months. However, in some 
patients, positive IgM T. gondii specific titers can be observed during 
the chronic stage of the infection. IgM antibodies have been reported 
to persist as long as 12 years after the acute infection. Persistence of 
these IgM antibodies does not appear to have any clinical relevance 
and these patients should be considered chronically infected. Their 
reliability for detection of IgM antibodies varies considerably however; 
false positive results have been a serious problem. 
IgA antibodies may be detected in sera of acutely infected adults 
and congenitally infected infants using ELISA or ISAGA methods. As is 
true for IgM antibodies to the parasite, IgA antibodies may persist for 
many months to more than one year. For this reason they are of little 
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additional assistance for diagnosis of the acute infection in the adult. 
In contrast, the increased sensitivity of IgA assays over IgM assays for 
diagnosis of congenital toxoplasmosis represents an advance in 
diagnosis of the infection in the fetus and newborn. In a number of 
newborns with congenital toxoplasmosis and negative IgM antibodies, 
the serological diagnosis has been established by the presence of IgA 
and IgG antibodies.  
IgE antibodies are detectable by ELISA in sera of acutely 
infected adults, congenitally infected infants, and children with 
congenital toxoplasmic chorioretinitis. The duration of IgE 
seropositivity is less than with IgM or IgA antibodies and hence 
appears useful as an adjunctive method for identifying recently 
acquired infections.  
Nowadays, various commercial ELISA kits are widely available 
for detection of IgG or IgM antibodies.  
 
 Voller et al. (1976) first to initiate preliminary studies on enzyme 
immunoassay method in a microplate for diagnosis of Toxoplasma 
infection and reported that there was a positive correlation between 
the enzyme immunoassay results and dye test and haemagglutination 
test titers. 
 
 Walls et al. (1977) described a detail ELISA procedure for 
toxoplasmosis in which an antigen derived from solubilized whole 
organisms utilized for the test. They have successfully used both the 
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tube and microtitration procedures for assay and reported that ELISA 
results were equivalent to those found in the indirect 
immunofluorescence test with 98 per cent specificity.  
 
Balsari et al. (1980) reported that the ELISA specificity looks 
comparable with that of the reference tests, as no sample classified as 
negative by all the reference tests was ELISA-positive and vice versa; 
ELISA appears to correlate better with haemagglutination and 
immunofluorescence, on the basis of the respective class frequencies; 
in particular, the number of positives, which was much lower for the 
dye-test and crossover-linked immunoassay, suggests that a higher 
sensitivity was reached in the former cases. 
 
Naot and Remington (1980) developed ELISA for detection of 
IgM antibodies to T. gondii, and stated that the IgM-ELISA was more 
sensitive than the IgM-IFA test in the diagnosis of recently acquired 
infection with T. gondii.  
Pappas et al. (1986) evaluated Dot-ELISA and compared with 
ELISA and IFA. They stated that the Dot-ELISA correlated well with 
the IFA test (correlation coefficient = 0.895) and the ELISA correlated 
slightly higher with the IFA test (correlation coefficient = 0.910) for 
detection of IgG antibodies to Toxoplasma. 
Susanto and Muljono (2001) attempted to detect T. gondii 
circulating antigen in 60 samples by using ELISA and it was shown 
that circulating antigen was found in 27 (90 per cent) from 30 
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samples which contained both IgG and IgM, whereas only 2 (66 per 
cent) from 30 samples which contained only IgG showed positive 
results. Therefore, circulating antigen detection can be used to 
identify the acute phase of infection. 
Filice et al. (1983) compared ELISA and IFA for the quantitation 
of IgG and IgM anti-toxoplasma antibodies on whole sera and purified 
IgM fractions. They stated that the conventional IgM ELISA was 
constantly negative when performed on both whole sera or pure IgM 
IFA positive fractions of the same newborns. 
Kodym et al. (2007) reported that detection of IgE ELISA 
appears to be a highly specific test for confirming the acute nature of 
Toxoplasma infections that have been detected by other sensitive 
methods like IgA and IgM ELISAs, IgG avidity assay and CFT. 
 
3.6 CD4+ / CD8+ COUNT OF T LYMPHOCYTES IN HIV PATIENTS  
         WITH SEROPOSITIVE TOXOPLASMOSIS 
 
CD4+ T-lymphocyte count is the standard method to evaluate 
the immunologic response to antiretroviral treatment and the ability 
to predict the development of opportunistic infections and viral load 
and can provide a good indicator of long-time prognosis of disease 
progression (Post et al., 1996). This group of blood cells is the target of 
HIV and a CD4+ count below 200 cells per µl makes it necessary to 
initiate anti-retroviral treatment. Otherwise, opportunistic infections 
which correlate to specific CD4+ counts can decrease the patient’s 
survival expectation. 
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 Hughes (2003) also stated that patients with CD4+ count of 
<100 per µl have more chance to develop toxoplasmosis,  
cryptococcosis and candidal esophagitis.  
 
Kumarasamy et al. (2003) reported from South India that the 
3.5 per cent of person with HIV (n=20) having mean CD4+ count of 
135 cells/ µl had CNS toxoplasmosis. They also stated that there was 
a progressive and highly significant inverse relationship between the 
CD4+ count with the increasing number of this opportunistic infection 
(p=0.001).  
 
Nissapatorn et al. (2003) reported an association between the 
level of CD4+ cell count and toxoplasmic encephalitis (p=0.019; 
OR=2.6; 95 % CI=1.14-6.02).  
 
Kasper (2005) quoted that Toxoplasmic Encephalitis (TE) occurs 
in 10–50 per cent of HIV-infected patients who were seropositive for 
antibodies to T. gondii and who had CD4+ count <100 cells/mm3. The 
greatest risk was among patients with a CD4+ T-lymphocyte count <50 
cells/mm3. The highest risk for HIV-infected patients with latent 
infection was when CD4+ count was <100 cells/mm3. Patients with 
positive IgG antibody to T. gondii and CD4+ count <200 cells/mm3 
should receive empiric therapy.   
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4. MATERIALS AND METHODS 
 
The present study was conducted at Tirunelveli Medical College 
Hospital, Palayamkottai, Tirunelveli District, Tamil Nadu from May’ 
2006 to October’ 2007 to assess the seroprevalence of toxoplasmosis 
in and around Tirunelveli by using in-house IgG assays viz., IFAT, 
MAT and ELISA using laboratory own prepared antigen. Various risk 
factors associated with in the study group was statistically analysed 
and results were interpreted.  
4.1    MATERIALS  
4.1.1 Study place and test material   
A total of 350 peripheral blood samples for this study were 
collected from 175 immunodeficient patients (HIV and malignant 
patients) and 175 immunocompetent patients like pregnant women 
(135), ocular chorioretinitis cases (20) and patients with 
lymphadenopathy (20), in and around Tirunelveli district of  
Tamil Nadu those admitted at Tirunelveli Medical College Hospital.   
4.1.2 Parasites  
Mouse adapted RH strain of Toxoplasma gondii maintained at 
the Department of Veterinary Parasitology, Madras Veterinary College, 
Chennai, which was originally obtained from All India Institute of 
Medical Sciences, New Delhi was used in this study.  
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4.1.3 Laboratory/experimental animals  
Swiss albino mice were procured from the Madras Veterinary 
College, Chennai. They were maintained on concentrate feed, fully 
soaked White Bengal gram and water ad lib.  
4.1.4 Cell lines  
Fibroblast cell lines, Madin Darby Canine Kidney (MDCK) and 
Murine Macrophage cell lines were procured from Department of 
Animal Biotechnology, Madras Veterinary College, Chennai. 
4.1.5 Chemicals, Immunobiologicals and plasticwares  
Chemicals were purchased from Himedia and Qualigens. 
Immunobiologicals were obtained from Bangalore Genei. Plastic tissue 
culture wares of Tarson and Laxbro make were used.  
4.1.6 Equipments  
The following equipments were used :  
Bright field microscope (Labomed), Inverted tissue culture  
microscope (Olympus ck-40), Laminar clean air-work station 
(Klenzaids), Fluorescent microscope (Labomed), Table top centrifuge 
(Remi, R8C), Carbondioxide incubator (Forma Scientific), Balance 
(Mettler, Toledo), Incubator (Tempo), ELISA reader and washer 
(BioRad, France),  Sonicator (B. Braun, Germany) and Flowcytometer 
(Becton Dickinson, USA). 
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4.1.7 Reference sera 
 The known positive and known negative Toxoplasma reference 
sera were gifted by Dr. C. Sreekumar, Toxo Laboratory, USDA, 
Beltsville, Maryland, U.S.A.   
METHODS 
 
4.2 General safety precautions and ethical clearance 
As all the stages of T. gondii are infective, the following safety 
precautions were followed during the course of the present study. All 
objects used in tachyzoite handling were washed thoroughly with 
water, followed by swabbing with alcohol. Face mask and goggles were 
used during cell culture work. Litter from mouse cages and floors of 
sheds were collected daily and disposed off after adding concentrated 
ammonia. All cages were thoroughly washed with 30 per cent 
ammonia solution between various batches of animals. Dead 
laboratory animals were immersed in 10 per cent formalin before 
disposal.  
Due consideration for animal ethical concern was made before 
implication of this study for rearing experimental animal, mice.  The 
Institutional Ethical committee clearance was obtained for this study.  
4.3 Maintenance of T. gondii (RH strain)  
 The recipe of the buffers used is appended in Annexure l.  
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4.3.1 In vivo propagation of T. gondii 
Mice infected with RH strain of T. gondii were maintained in the 
small laboratory animal facility and examined for signs of infection as 
per the method adopted by Derouin et al. (1987). The animals showing 
extreme dullness were euthanized by chloroform anaesthesia and the 
peritoneal cavity was opened aseptically (Plate 4). Using an insulin 
syringe, the ascitic fluid (peritoneal exudate) was aspirated and 
diluted in about 1 ml of sterile phosphate buffered saline (PBS, pH 
7.2). A drop of this fluid was examined microscopically for the 
presence of tachyzoites and there after the dried smear was stained 
with Leishman’s and Giemsa’s stain (Plate 5). About 0.3-0.5 ml of the 
ascitic fluid preparation, containing 5-10 parasites per high power 
field, was inoculated intraperitoneally to healthy mice for further 
maintenance and production of tachyzoites. The tachyzoites thus 
harvested were counted (as described below in 4.3.3) and prepared as 
antigen which was used for immuno assays.  
4.3.2   In vitro cultivation of T. gondii   
Seed cultures of fibroblast (MDCK) cell lines were maintained as 
per the procedure of Hughes et al. (1986)  in prescription and/or milk 
dilution bottles in RPMI-1640 medium supplemented with 5 per cent 
neonatal calf serum, 25 mM HEPES, 2 mM L-glutamine and 50 µg/ml 
gentamicin. Cultures were incubated in a BOD incubator at 37°C. 
Fresh monolayers were split from confluent seed cultures and used for 
in vitro infection with T. gondii tachyzoites, as described below.  
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Infected mice were sacrificed in extremis by chloroform 
anaesthesia. They were thoroughly scrubbed with absolute alcohol to 
remove extraneous dirt and other body fluids. The mice were then 
dipped once in alcohol before transfer to a laminar clean air work 
station and placed on dorsal recumbency. Using sterile forceps, the 
skin over the abdomen was lifted and incised with a pair of scissors to 
expose the abdominal muscles. The peritoneal cavity was then opened 
by cutting through the muscle layers, exposing the visceral organs. A 
drop of the peritoneal fluid was then aspirated into a sterile insulin 
syringe containing about 0.5 ml of plain medium. If peritoneal fluid 
was scanty, then a small quantity of plain medium was instilled onto 
the visceral organs and immediately aspirated. Care was taken not to 
puncture the intestines during this process.   
A drop of the fluid thus collected was transferred to a glass slide 
(sterilized over flame) and examined for the presence of tachyzoites 
and absence of gross bacterial contamination. After ensuring the 
sterility of the tachyzoite preparation, it was directly transferred to 25 
cm2 culture flasks containing confluent monolayers. Coverslip 
cultures of murine macrophage cell line, grown in 24-well plates with 
0.5 ml of medium, were also infected as per the method of 
Chamberland and Current (1991). The cultures were incubated in Co2 
incubator at 5 per cent Co2 tension and 37oC.  
The medium was replaced after 24 hr and the cultures were 
examined daily for signs of infection under an inverted microscope 
(Plate 6). The medium from the infected culture flasks was partially 
replaced as and when acidic pH conditions were noticed. The rate of 
multiplication of the tachyzoites was periodically monitored. 
Coverslips from the 24 -well plates were removed at intervals, fixed in 
Bouin's or methanol, stained with 10 per cent Giemsa solution and 
examined using a bright field microscope (Plate 6). Once the 
monolayers of host cells were totally taken over and disrupted 
releasing the tachyzoites, a small aliquot of the supernate (~0.2 ml) 
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was transferred to a freshly split monolayer to maintain the infection 
for subculture.  
4.3.2.1 Recovery of tachyzoites from in vitro culture  
 Culture supernates were harvested from flasks previously 
infected with T. gondii tachyzoites, after the complete disruption of 
monolayers. The medium from all the flasks was removed after 
vigorous pipetting to release all the attached cells. These supernates, 
consisting mainly of free tachyzoites and heavily infected macrophage 
cells were washed twice in PBS (pH 7.2). The material was centrifuged 
at 500 g for 5 minutes and the pellet was resuspended in 1 ml of PBS. 
The number of free tachyzoites was then counted. 
4.3.3 Counting of tachyzoites  
 
The tachyzoite suspension harvested from mice inoculation or 
by tissue culture was thoroughly pipetted to break down clumps and 
two dilutions, 10-fold and 100-fold, were prepared for counting. The 
first dilution was made by adding 10 µl of tachyzoite suspension to 90 
µl of Trypan blue (0.4 per cent) solution (10-fold dilution). The second 
dilution was then made by adding 10 µl of this tachyzoite preparation 
(10-fold dilution) to 90 µl of Trypan blue (100-fold dilution). Ten 
microlitres of each of these dilutions were charged to the two 
chambers of a haemocytometer. After allowing the tachyzoites to 
settle, the unstained (viable) tachyzoites were counted in four corner 
squares (WBC chamber) using 40x objective. From this value, the total 
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number of tachyzoites/ml of suspension was calculated using the 
following formula:  
 Tachyzoites per millilitre = Average number of tachyzoites (from  
                                               4 corner squares) x Dilution factor x 104.  
Values were considered only if those of the two dilutions were 
concordant.  
4.3.4 Preparation of tachyzoites antigen 
 
After counting the number of free tachyzoites, the material was 
resuspended in an appropriate volume of PBS and centrifuged again. 
After the centrifugation tachyzoites were suspended in 6 per cent 
formaldehyde solution. The tachyzoites were kept overnight in this 
solution. After 16 hours of suspension in formaldehyde, they were 
centrifuged and resuspended in PBS. The sediment was washed thrice 
in PBS, to remove cell debris and the formaldehyde. Finally the 
tachyzoite antigen was resuspended in an appropriate volume of PBS, 
made as different aliquots and stored at -20°C until use. The antigen 
thus prepared was used for the immunoassay.          
4.4 Collection of test material from patients  
4.4.1 Study place and period 
 The study was conducted at Tirunelveli Medical College 
Hospital, Palayamkottai, Tirunelveli District, Tamil Nadu from May’ 
2006 to October’ 2007. 
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4.4.2 Study population 
A total of 350 peripheral blood samples for this study were 
collected from 175 immunodeficient patients (HIV and malignant 
patients) and 175 immunocompetent patients like pregnant women 
(135), ocular chorioretinitis cases (20) and patients with 
lymphadenopathy (20) in and around Tirunelveli district of  
Tamil Nadu those admitted at Tirunelveli Medical College Hospital.   
4.4.3 Socio-demographic, Clinical and Behavioral data 
The history of illness and patients information and socio-
demographic data like epidemiological risk, antenatal risk, HIV risk 
and clinical risk assessment factors were collected in the specially 
designed data sheet (appended in Annexure II) for this purpose. 
Socio-demographic data including age, education, occupation, parity, 
residency and related risk factors including source of drinking water, 
obstetrical history, frequency and type of meat, vegetables, fruits and 
milk consumption, cooking preferences, owning cat, history of 
cleaning cat litter box or feeding raw meat scraps, history of blood 
transfusion, organ transplant etc., were collected for further analysis. 
 
4.4.3  Separation of sera 
 
About 2-5 ml of blood collected from each patient was separated 
after centrifugation. The sera collected were inactivated at 56°C for 30 
minutes in water bath and stored in small aliquots at –20°C. 
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4.5   EVALUATION OF IgG BASED ASSAYS FOR  
           SERODIAGNOSIS OF TOXOPLASMOSIS 
4.5.1  INDIRECT FLUORESCENT ANTIBODY TEST (IFAT) 
4.5.1.1  Standardization of IFAT  
 The recipe of the buffers used is appended in Annexure l.  
4.5.1.1.1 Preparation of antigen slides  
Antigen slides were prepared as per the procedure outlined in 
USHDEW manual (1976) with minor modifications.  
The formalin killed T. gondii tachyzoite antigen harvested from 
the cell line culture was resuspended in an appropriate volume of PBS 
(so as to obtain 100-200 tachyzoites per high power field). The 
suspension was then drawn into a capillary tube and spotted onto 
grease-free Teflon coated slides on which circular wells were 
previously etched using a glass marking pencil. Once the spots had 
dried up, the slides were placed in cold acetone overnight. The fixed 
slides were air-dried, wrapped in aluminium foil and stored at –20oC 
until further use.  
4.5.1.1.2 Reference sera  
The known positive and negative sera obtained from the 
reference lab were aliquoted and stored at –20oC until use.  
4.5.1.1.3 Conjugates  
Anti-human IgG-FITC conjugate raised in goat was obtained 
from Bangalore Genei.  
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4.5.1.1.4 Standardisation of IFAT 
Optimum working dilution of conjugate was standardised. The 
conjugate dilutions of 1:25, 1:50, 1:100 and 1:200 were tested with 
known positive and negative sera. The optimum dilution, which gave 
the highest titre with positive sera and lowest negative sera titre, was 
selected. The sensitivity, specificity and positive and negative 
predictive value of the assay were calculated using 10 known positive 
and negative reference sera.  
4.5.1.2 IFA Test procedure  
IFAT was performed as described by Renterghem and Nimmen 
(1976) and USHDEW manual (1976) with minor modifications. Briefly, 
the following procedure was adapted.  
) The formalin killed acetone fixed antigen slides were thawed at 
room temperature before use.  
) Ten µl of diluted sera was added to the spots. Test sera were 
used in 3 dilutions of 1 in 8, 1 in 16 and 1 in 32 in PBS.  
) Positive and negative control sera were diluted to 1 in 16 and 1 
in 8, respectively.  
) The slides were then incubated for 1 hr at 37oC in a humid 
chamber.  
) They were then washed in distilled water and PBS.  
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) After drying on a blotting paper, 10 µl of Goat Anti-human IgG-
FITC conjugate of 1 in 50 dilution was added to the antigen 
spots.  
) The slides were washed as before and dried.  
) A drop of buffered glycerol was added to the spots and a 
coverslip was placed.  
) The slides were examined immediately at 40x magnification 
using a fluorescent microscope.  
) Positivity and negativity were determined as per the guidelines 
described (USHDEW manual, 1976).  
) Test sera samples that were positive at 1:16 dilution were 
further tested at two fold serial dilutions until an end point was 
reached.    
4.5.2 ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 
4.5.2.1  Standardization of IgG ELISA  
The recipe of the buffers used is appended in Annexure l.  
4.5.2.1.1 Preparation of tachyzoite soluble antigen (TSA) 
Purified formalin killed tachyzoites were lysed with distilled 
water and then disrupted by six successive cycles of freezing and 
thawing. The material was centrifuged at 3,000 g at 4°C for 30 
minutes. The sediment was resuspended in 4 ml PBS and was 
sonicated (B. Braun Sonifier, Germany) at constant power on high 
setting with repeated duty cycles per 0.3 seconds for 5 minutes for 3 
cycles in ice bath of 40C. The disruption was confirmed by light 
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microscopic examination. The sonicated material was then centrifuged 
at 15,000 rpm at 40C for 30 minutes. The supernatant fluid was taken 
as tachyzoite soluble antigen (TSA) and stored at –200C until use.  
4.5.2.1.2  Protein estimation  
The protein content of tachyzoite soluble antigen (TSA) as 
determined by the Lowry et al. (1951) method was approximately 0.63 
mg/ml. 
 
4.5.2.1.3   Conjugate 
 
Commercially available horseradish peroxidase conjugated goat 
anti-human IgG (Genbio, Taiwan) was used for the ELISA. 
 
4.5.2.1.4   Substrate 
 
Commercially available substrate solution Tetramethyl 
benzididine (TMB, Genbio, Taiwan) of 0.6 mg / ml of TMB in citric 
acid buffer plus 0.02 per cent H2O2 was used.  
4.5.2.1.5   Standardization of ELISA by Chequer board titration 
Optimum working dilution of antigen, sera and conjugate was 
determined by chequer board titration using serial dilution of serum, 
antigen and conjugate. 
 The sera were diluted as 1:50, 1:100, 1:200 and 1:400 and 
these were tested in a chequer board titration with known positive 
antigen serially diluted. The optimum dilution, which gave maximum 
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difference between negative and positive antigen was selected as the 
working dilution of serum for use.  
Similarly, the antigen dilution was also standardized at various 
concentrations of 5, 10, 20 and 40 µg/ml. The conjugate dilutions of 
1:500, 1:1,000, 1:5,000 and 1:10,000 were tested by chequer board 
titration with serially diluted known positive and negative sera and 
antigen. The optimum dilution, which gave the highest ratio between 
positive and negative control sample was selected.  
The sensitivity, specificity and positive and negative predictive 
value of the assay were calculated using 10 known positive and 
negative reference sera. 
 
4.5.2.2  Test procedure for in-house IgG Micro-ELISA  
 
In-house IgG Micro-ELISA was performed as described by Voller 
et al. (1976) with minor modifications. Briefly, the following procedure 
was followed.  
( The 96-well flat bottom polystyrene microtitre (ELISA) plate 
(Tarsons, India) was recharged by filling up the wells with 
lukewarm water at least for 15 minutes. Thereafter the water was 
discarded by inverting and shaking the plate. 
( The predetermined antigen solution (10 µg of TSA/ml) was 
prepared in 0.05 M Carbonate-bicarbonate buffer. Hundred µl of 
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antigen was coated in the ELISA plate and incubated at 40C for 
overnight. 
( The plate was then washed with PBS – T for three times. 
( Thereafter 100 µl of 1 per cent skimmed milk solution in PBS-T 
was added into the plate and incubated for 1 hour at 370C.   
( The plate was then washed with PBS – T for three times. 
( Then 100 µl of test sera prepared at 1:100 dilution was added to 
the plate. The positive and negative sera controls of same dilutions 
were added in the respective wells.  
( The plate was incubated for one hour at 370C. The plate was 
washed with PBS –T for 3 times. 
( One hundred µl of 1:1,000 goat antihuman IgG HRP conjugate 
diluted in PBS-T was added on each well and incubated at 370C for 
one hour. 
( The plate was washed with PBS – T for 3 times. 
( One hundred µl of TMB substrate solution was added in each well 
and incubated in a dark room at room temperature for 15 minutes 
and the reaction was stopped by adding 100 µl of 1M Sulphuric 
acid.   
( The substrate and conjugate control was maintained in each plate. 
 51
( The optical density (OD) values were read in Multiscan ELISA 
reader (Biorad, France) at 450 nm reference filter. 
 
4.5.2.3  Interpretation of ELISA 
  
 The cutoff value was calculated by adding mean OD value of two 
negative controls and mean OD value of 3 positive controls and the 
sum is divided by six. The test sera with absorbance values less than 
the cutoff value were considered nonreactive and test sera with 
absorbance values equal or greater than the cutoff value were 
considered reactive.  
 
4.5.3  MODIFIED DIRECT AGGLUTINATION TEST (MAT) 
4.5.3.1  Standardization of MAT  
The recipe of the buffers used is appended in Annexure l.  
4.5.3.1.1 Preparation of MAT antigen 
     
Direct agglutination method described by Desmonts and 
Remington (1980) was followed with minor modification (Singh  
et al., 1996).  
Ten mice were infected with RH strain of T. gondii maintained in 
the small laboratory animal facility and examined for signs of 
infection. On 5 days post infection the mice were euthanized by 
chloroform anaesthesia and the peritoneal cavity was opened 
aseptically. Using an insulin syringe, the ascitic fluid (peritoneal 
 52
exudate) was aspirated and diluted with sterile phosphate buffered 
saline (PBS, pH 7.2). A drop of this fluid was examined 
microscopically for the presence of tachyzoites. Repeated washing of 
the peritoneal cavity with sterile PBS was carried out to collect 
maximum tachyzoites. The tachyzoites thus harvested were counted 
and the Formalin killed freshly prepared antigen was reconstituted in 
sterile PBS so as to reach the final concentration of 1 x 107 tachyzoites 
per ml, which was used for the MAT.  
4.5.3.1.2 Preparation of MAT antigen mixture  
 Antigen diluting Borate buffer was prepared by dissolving 7.01 g 
of Sodium chloride, 3.09 g Boric acid, 2 g Sodium azide in 900 ml 
deionised water. Twenty four ml of 1N NaOH was added to this and 
the pH was adjusted to 8.95. The volume was made up to 1 litre and 
used as stock solution which was stored at room temperature. 
For the preparation of working antigen diluting buffer, 0.4 g of 
Bovine Serum Album in was dissolved in 100 ml of Borate buffer and 
stored at 4°C. For each plate, 2.5 ml of antigen diluting buffer was 
mixed with 35 µl of 2-mercaptoethanol, 50 µl of Evans blue dye 
solution as tachyzoite colouring agent and 0.15 ml of Formalin killed 
antigen, which was used as antigen mixture for the MAT.  
4.5.3.1.3 Standardisation of MAT 
 The sensitivity, specificity and positive and negative 
predictive value of the assay were calculated using 10 known positive 
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and negative reference sera. End titre of positive sera control was 
standardised.  
4.5.3.1.1 Test procedure of MAT 
( The serum samples were diluted with sterile serum diluting buffer 
(PBS of pH 7.2) in microtitre plates. The initial dilution was started 
at 1:20. 
( Twenty five µl of antigen mixture was added to each well on U 
bottom microtitre plate (Tarson) immediately after mixing.   
( Twenty five µl of serum of all dilutions prepared as above were 
added. 
( The antigen and sera were mixed by repeated pipetting action and 
the plate was covered with sealing tape.  
( The positive and negative controls were maintained in each plate 
( The plate was read after overnight incubation at 37°C.  
( The negative reaction was indicated by formation of blue button at 
the bottom of the well whereas; the positive reaction had matted 
appearance.  
( Antibody titres of 1:20 or more were taken as significant for 
reporting positive results. Those test samples positive at 1:20 were 
further serially two fold diluted until the end titre was reached.  
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4.5.4 CD4+/CD8+ COUNT OF T LYMPHOCYTES IN HIV PATIENTS 
OF SEROPOSITIVE AND SERONEGATIVE GROUP OF 
TOXOPLASMOSIS 
 
CD4+ and CD8+ count of T lymphocytes in peripheral blood was 
assessed by flow cytometry in HIV positive patients. The CD4+ and 
CD8+ count in the seropositive and seronegative toxoplasmosis group 
was compared and interpreted.  
 
4.5.4.1       Immuno cytometry  
 
4.5.4.1.1 Collection of blood 
 
The blood samples of the patients were collected with all  
bio-safety precautions; initially 3 ml, in plastic vials for HIV testing 
and later 2 ml, in K-3 liquid EDTA vacutainer (Becton Dickinson, 
Mountain View CA) for CD4+/CD8+ testing.  
 
4.5.4.1.2 HIV testing 
 
Sera were separated on the same day and tested for HIV 
antibodies on the same/following day of collection, by WHO approved 
ELISA/Rapid kits supplied by MicroElisa, New Delhi, following its 
testing guidelines. All samples were tested by the same kit 
manufactured by the same company.  
4.5.4.1.3 CD4+/CD8+ testing  
 
The blood samples were processed immediately within 2 hours 
of collection, for determining the absolute counts of CD4+ and CD8+ 
cells and their ratios by two colour immunophenotyping on the single 
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platform fluorescence activated cell sorting (FACS) count system 
(Becton Dickinson Pvt. Ltd., Mountain View, CA. Plate 7), using 
fluorochrome labeled monoclonal antibodies to CD4+/CD8+ T-cells, as 
per the method of Kumarasamy et al. (2003). The same batches of 
antibodies were used for testing the samples of subjects of all the 
groups. FACS count protocol software versions 1.0 (2005) (Becton 
Dickinson) were used for data acquisition and analysis. 
 
4.5.4.1.4 Statistical analysis  
 
Differences between mean CD4+, CD8+ and CD4+/CD8+ count of 
seropositive and seronegative toxoplasmosis patient in HIV group was 
compared and analysed.  
 
4.5.5 EVALUATION OF DIFFERENT SERODIAGNOSTIC METHODS  
         FOR SEROPREVALENCE OF TOXOPLASMOSIS 
  
 
The sensitivity, specificity, positive predictive value and negative 
predictive value of the three IgG based assays viz., IFAT, MAT and 
ELISA for seroprevalence of toxoplasmosis was compared and the 
testing efficiency of the assays was statistically interpreted.  
 
4.5.5.1      Statistical analysis 
 
4.5.5.1.1 Test of significance of IFA, MAT and ELISA by     
                 McNemar’s test for paired samples                
 
 
The testing efficiency of the three assays IgG based assays viz., 
IFAT, MAT and ELISA for seroprevalence of toxoplasmosis was 
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statistically analysed for its significance by McNemar’s test (Armitage 
and Berry, 1987). 
 
The ‘z’ value was calculated by the following formula 
    r- ½n 
  z  =     -------          follows normal distribution with  
     ½ √n         degree of freedom (n-1) 
 
where,  
 
z = Calculated value 
r = Number of seropositivity of the first test and seronegativity of  
               the compared test (test 2) 
 
n = Number of untied pairs 
 
and the test of significance at p<0.05 / p<0.01  was interpreted.  
 
 
4.5.6 SEROPREVALENCE OF TOXOPLASMOSIS IN TIRUNELVELI  
         DISTRICT 
 
All the collected sera (n=350) were subjected into three IgG 
based assays viz., IFAT, MAT and ELISA for seroprevalence of 
toxoplasmosis. The results of the three assays were compared and 
statistically interpreted.  
 
Seroprevalence of toxoplasmosis in the different groups of 
patients in and around Tirunelveli District of Tamil Nadu using three 
IgG based assays viz., IFAT, ELISA and MAT was statistically 
analysed. Seroprevalence of toxoplasmosis in pregnant women based 
on gravida, trimester of pregnancy and bad obstetric history was 
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compared. The various socio demographic risk factors associated with 
seroprevalence of toxoplasmosis in Tirunelveli District was analysed.  
  
4.5.6.1 Statistical analysis  
 
  
 The odds ratio (OR) and 95 % confidence interval (CI) range was 
calculated for each risk factors of different category of case control 
study using David Hutchon’s odds ratio calculating software.  
 
The Chi-squared test was calculated for the analytic assessment 
by SPSS 11.5 version software and the p value was calculated using 
VassarStat software. The differences were considered to be statistically 
significant when the p value obtained was less than 0.05 (p<0.05).  
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5. RESULTS 
 
 
5.1  COLLECTION OF TEST MATERIAL FROM PATIENTS  
 The study was conducted at Tirunelveli Medical College 
Hospital, Palayamkottai, Tirunelveli District, Tamil Nadu from May 
2006 to October 2007. A total of 350 peripheral blood samples for this 
study were collected from 175 immunodeficient patients (HIV and 
malignant patients) and 175 immunocompetent patients like pregnant 
women (135), ocular chorioretinitis cases (20) and patients with 
lymphadenopathy (20) admitted at Tirunelveli Medical College 
Hospital those residing in and around Tirunelveli District of  
Tamil Nadu (Fig. 1a and 1b).   
 
5.2  PREPARATION OF T. GONDII TACHYZOITE ANTIGEN 
 
The T. gondii (RH strain) tachyzoite antigen was prepared by  
in vivo mice propagation and in vitro cell culture system in MDCK 
fibroblast cell line.  The tachyzoites count was 1 x 107 and 1 x 109 per 
ml of antigen by in vivo and in vitro methods respectively. Formalin –
killed T. gondii tachyzoite antigen was prepared for IFAT and MAT. The 
tachyzoite soluble antigen (TSA) with protein concentration of 0.63 
mg/ml was prepared and used for ELISA.  
 
5.3   EVALUATION OF IgG BASED ASSAYS FOR  
           SERODIAGNOSIS OF TOXOPLASMOSIS 
5.3.1  INDIRECT FLUORESCENT ANTIBODY TEST (IFAT) 
5.3.1.1  Standardization of IFAT  
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An IFAT was standardized using reference control positive and 
negative sera. The optimum dilution of conjugate was standardized. 
The conjugate dilutions of 1:25, 1:50, 1:100 and 1:200 were tested 
with known positive and negative reference sera. The optimum 
conjugate dilution, of 1 in 50 which gave the highest titre with positive 
sera and lowest negative sera titre, was selected. The positive sera 
from minimum dilution of 1:16 to maximum up to 1:512, showed good 
immunoreactivity with either bright yellow-green fluorescence over the 
entire tachyzoite or distinct yellow-green fluorescence around the 
entire periphery of the organism (which appeared reddish). With 
negative control serum (1:8), the organisms did not show any 
fluorescence or sometimes polar fluorescence was also seen (Plate 8). 
Therefore the cut-off titre for positive was arrived at 1:16 and above.  
 
5.3.1.2 Evaluation of IgG IFAT   
 
 
The sensitivity, specificity, positive and negative predictive value 
of IgG IFAT in detecting toxoplasmosis was 80, 90, 88.89 and 81.81  
per cent, respectively (Table - 4). 
5.3.2 ENZYME LINKED IMMUNOSORBENT ASSAY 
(ELISA) 
5.3.2.1  Standardization of IgG ELISA  
The tachyzoite soluble antigen (TSA) was prepared and the 
protein concentration was determined which approximately amounts 
to 0.63 mg/ml. The antigen concentration was standardised at         
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10 µg/ml.  The optimum dilution of serum and conjugate were found 
to be 1:100 and 1:1,000 respectively, by chequer board titration. 
5.3.2.2 Interpretation of IgG ELISA 
 
The cutoff value was calculated by adding mean OD value of two 
negative controls and mean OD value of 3 positive controls and the 
sum is divided by six. The cutoff value for the IgG ELISA was found to 
be 0.144. The test sera with absorbance values less than this cutoff 
value were considered nonreactive and test sera with absorbance 
values equal or greater than this cutoff value were considered reactive 
(Plate 9). 
 
5.3.2.3 Evaluation of IgG ELISA 
 
 
The sensitivity, specificity, positive and negative predictive value 
of IgG ELISA in detecting toxoplasmosis was 90, 100, 100 and 90.9 
per cent, respectively (Table - 5). 
5.3.3  MODIFIED AGGLUTINATION TEST (MAT) 
5.3.3.1  Standardization and interpretation of MAT  
 
The formalin killed antigen mixture containing 1x107 
tachyzoites per ml with 2-mercaptoethanol and Evans blue was 
prepared and used for MAT. The negative reaction was indicated by 
formation of blue button at the bottom of the well whereas, the 
positive reaction had matted appearance (Plate 10). Antibody titers of 
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1:20 or more were taken as significant for reporting positive results. 
Those samples positive at this dilutions were further diluted up to 
1:10,240 to get the end titer. 
 
5.3.3.2 Evaluation of MAT 
 
 
The sensitivity, specificity, positive and negative predictive value 
of MAT in detecting toxoplasmosis was 80, 90, 88.89 and 81.81 
per cent, respectively (Table - 6). 
5.3.4 COMPARATIVE EVALUATION OF THREE IgG BASED 
ASSAYS FOR ITS SENSITIVITY AND SPECIFICITY FOR 
DETECTING TOXOPLSMOSIS  
 
The comparative evaluation of three IgG based assays viz., IFAT, 
ELISA and MAT for detecting toxoplasmosis is presented in the Table 
7 and Fig. 2. Among the three assays, IgG ELISA was found to be 
highly sensitive (90 per cent) and specific (100 per cent) in detecting 
toxoplasmosis, whereas the IgG IFAT and MAT were equal in 
sensitivity (80 per cent) and specificity (90 per cent). The positive and 
negative predictive value of ELISA was 100 and 90.9 per cent, 
respectively.  
 
5.4.  SEROPREVALENCE OF TOXOPLASMOSIS  
5.4.1 Seroprevalence of toxoplasmosis by IgG IFAT 
Out of 350 patients tested by IgG IFAT, 41 patients (11.71 per 
cent) had antibodies for toxoplasmosis with mean IFAT titre of 43.42 ± 
58.7 and the titre ranged from 1:16 to 1:256. Among the 
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immunocompetant group of 175 patients, 19 patients (10.86 per cent) 
had antibodies to toxoplasmosis whereas in immunodeficient group of 
175 patients, 22 patients (12.57 per cent) had antibodies for 
toxoplasmosis (Table 8 and Fig. 3).   
 
Out of 135 pregnant women tested, 13 (9.63 per cent) were 
seropositive with mean IFAT titre of 51.69 ± 74.23 (titre ranged from 
1:16 to 1:256). Among the 20 cases of lymphadenopathy, only 3  
(15 per cent) were seropositive with mean titre of 26.6 ± 9.23 (titre 
ranged from 1:16 to 1:32). Of the 20 ocular cases tested, only 3  
(15 per cent) were seropositive with mean titre of 58.67 ± 60.57 (titre 
ranged from 1:16 to 1:28). 
 
Among the 160 HIV positive individuals tested by IFAT, 19 
(11.88 per cent) were seropositive with mean titre of 45.47 ± 61.33 
(titre ranged from 1:16 to 1:256). Out of 15 cases of malignancy, only 
3 (20 per cent) were seropositive with mean titre of 26.6 ± 9.23 (titre 
ranged from 1:16 to 1:32).  
 
5.4.2 Seroprevalence of toxoplasmosis by IgG ELISA 
  
Out of 350 patients tested by IgG ELISA, 46 patients (13.14 per 
cent) had antibodies for toxoplasmosis with mean OD value of 0.2 ± 
0.073 and the OD value ranged from 0.144 to 0.444. Among the 
immunocompetant group of 175 patients, 19 patients (10.86 per cent) 
had antibodies to toxoplasmosis whereas, in immunodeficient group of 
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175 patients, 27 patients (15.43 per cent) had antibodies for 
toxoplasmosis (Table 9 and Fig. 5). 
 
Out of 135 pregnant women tested, 13 (9.63 per cent) were 
seropositive with mean OD value of 0.191 ± 0.069 (OD value ranged 
from 0.148 to 0.357). Among the 20 cases of lymphadenopathy, only 3  
(15 per cent) were seropositive with mean OD value of 0.162 ± 0.029 
(OD value ranged from 0.144 to 0.196). Of the 20 ocular cases tested, 
only 3 (15 per cent) were seropositive with mean OD value of 0.179 ± 
0.043 (OD value ranged from 0.147 to 0.228). 
 
Among the 160 HIV positive individuals tested by IgG ELISA, 24 
(15 per cent) were seropositive with mean OD value of 0.212 ± 0.079 
(OD value ranged from 0.146 to 0.444). Out of 15 cases of malignancy, 
only 3 (20 per cent) were seropositive with mean OD value of 0.173 ± 
0.025 (OD value ranged from 0.146 to 0.196). 
 
5.4.3 Seroprevalence of toxoplasmosis by MAT 
 
Out of 350 patients tested by MAT, 39 patients (11.41 per cent) 
had antibodies for toxoplasmosis with mean MAT titre of 53.85 ± 
55.28 and the titre ranged from 1:20 to 1:160. Among the 
immunocompetant group of 175 patients, 18 patients (10.29 per cent) 
had antibodies to toxoplasmosis whereas in immunodeficient group of 
175 patients, 21 patients (12.0 per cent) had antibodies for 
toxoplasmosis (Table 10 and Fig. 4).   
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Out of 135 pregnant women tested, 12 (8.89 per cent) were 
seropositive with mean MAT titre of 55 ± 63.32 (titre ranged from 1:20 
to 1:160). Among the 20 cases of lymphadenopathy, only 3  
(15 per cent) were seropositive with mean titre of 33.33 ± 11.54 (titre 
ranged from 1:20 to 1:40). Of the 20 ocular cases tested, only 3  
(15 per cent) were seropositive with mean titre of 73.33 ± 75.71 (titre 
ranged from 1:20 to 1:160). 
 
Among the 160 HIV positive individuals tested by MAT, 18 
(11.25 per cent) were seropositive with mean titre of 50 ± 51.44 (titre 
ranged from 1:20 to 1:160). Out of 15 cases of malignancy, only 3 (20 
per cent) were seropositive with mean titre of 33.33 ± 11.54 (titre 
ranged from 1:20 to 1:40).  
  
5.4.4 Comparison of three IgG based assays for seroprevalence of 
toxoplasmosis in and around Tirunelveli  
  
The three IgG based assays viz., IFAT, ELISA and MAT for 
detection of toxoplasmosis was compared and is presented in Table 
11 and Fig. 6. Among the three assays, IgG ELISA was detected 46 
(13.14 per cent) seropositive cases out of 350 patients tested, whereas 
in IFAT it was 11.71 per cent and in MAT it was only 11.14 per cent. 
Therefore, IgG ELISA detected more number of seropositive cases than 
the other tests. The overall seroprevalence of toxoplasmosis in and 
around Tirunelveli District of Tamil Nadu was arrived as 13.14  
per cent based on IgG ELISA.  
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5.4.5 Comparison of testing efficiency of three IgG based assays 
by McNemar’s test of significance  
  
The testing efficiency of the three IgG based assays viz., IFAT, 
ELISA and MAT was statistically compared for its test of significance 
by McNemar’s test, which is depicted in the Table 12. Statistically 
there was no significant difference between IgG IFA and MAT in 
detecting toxoplasmosis. The significant difference was noticed 
between IFA and ELISA at p<0.05 whereas, the significant difference 
at p<0.01 was found between MAT and ELISA in detecting 
toxoplasmosis. Statistically the testing efficiency of IgG ELISA for 
detecting toxoplasmosis was higher than the other two tests.   
  
5.5.  ANALYSIS OF VARIOUS RISK FACTORS ASSOCIATED WITH 
THE SEROPREVALENCE OF TOXOPLASMOSIS IN AND 
AROUND TIRUNELVELI 
 
5.5.1. Seroprevalence of toxoplasmosis in pregnant women  
 
The seroprevalence of toxoplasmosis in pregnant women in and 
around Tirunelveli based on gravid, trimester of pregnancy and bad 
obstetric cases is presented in Table 13a, 13b and 13C and  
Fig 7a, 7b and 7c.  
 
Among the 135 pregnant women tested, 13 (9.63 per cent) were 
seropositive for toxoplasmosis. Out of 52 primi tested, 5 (9.62  
per cent) and 21 Gravida-3 (G3) tested 2 (9.52 per cent) were 
seropositive for toxoplasmosis.  
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Seroprevalence of toxoplasmosis during I, II and III Trimester of 
pregnancy was noticed in 9.1, 13.6 and 7.5 per cent cases 
respectively. Out of 19 cases with bad obstetric history (like abortion / 
premature delivery), only 3 (15.79 per cent) were seropositive for 
toxoplasmosis.  
5.5.2. Analysis of socio demographic risk factors associated with 
the seroprevalence of toxoplasmosis   
 
Various socio demographic risk factors like age, gender, 
residence, water source, diet and animal contact, associated with the 
seroprevalence of toxoplasmosis in and Tirunelveli is presented in 
Table 14. The statistical analysis was worked out by Odds ratio (OR) 
with 95 per cent Confidence interval (CI) range and the p value was 
arrived by Chi-squared test for significance.   
 
There was a significant difference between sex of the study 
population and drinking water source. Seroprevalence was increased 
in the male (19.12 %, p=0.0075, OR=2.316, 95 % CI=1.2362-4.3405) 
than the female and with river water consumption other than bore 
water (12.5 %, p=0.0483, OR=0.857, 95 % CI=0.1853-3.4641). No 
significant relations were observed between anti-Toxoplasma IgG 
antibodies and age, residence, diet and animal contact in the study 
population.  
 
5.5.2.1. Seroprevalence of toxoplasmosis according to age and sex 
  
The seroprevalence of toxoplasmosis according to age and sex of 
the study group was depicted in the Table 15. Among the different 
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age groups (<20 – 80 years) studied, there was significant difference 
between 21-30 years group than the other (p=0.02, OR=3.46, 95 % 
CI=1.08 -11). In this age group, there was 26.32 and 9.33 per cent of 
seroprevalence in male and females respectively. 
  
5.5.2.2. Seroprevalence of toxoplasmosis in different regions in   
     Southern Districts of Tamil Nadu 
 
Seroprevalence of toxoplasmosis in different regions in Southern 
Districts of Tamil Nadu is presented in Table 16. Out of 208 patients 
belonging to rural area and 56 cases of urban area of Tirunelveli 
District tested, 33 (15.71 per cent) and 9 (10.71 per cent) were had 
anti-Toxoplasma antibodies, respectively.  
  
There was a significant difference between the urban and rural 
areas of Tuticorin District with respect to the seroprevalence of 
toxoplasmosis, at p=0.0161, OR=1.09, 95 % CI=0.116-10.26. Out of 
65 patients belonging to rural area and 12 cases of urban area of 
Tuticorin District tested, 5 (7.69 per cent) and 1 (8.33 per cent) were 
had anti-Toxoplasma antibodies, respectively. Among the 5 patients 
belonging to rural area of Kanyakumari District tested, only 1 (20  
per cent) had anti-Toxoplasma antibodies.  
 
5.5.2.3 Analysis of risk factors in HIV patients with seropositive  
   and seronegative group of toxoplasmosis 
 
The various risk factors like sexual behaviour, vertical 
transmission, blood transfusion, I/V drug abuser, Needle injury/ 
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surgery and different stages of HIV infection and their influence in 
toxoplasmosis seropositive group is depicted in Table 17. 
  
Male HIV patients with multiple heterosexual behaviour were 
observed to be having higher seropositivity for toxoplasmosis (25.58 
per cent) than single sexual behaviour. Among the different stages of 
HIV infections, seroprevalence of toxoplasmosis was found in 22.91 
per cent of males and 9.09 per cent of females in Stage III group.   
 
5.6 COMPARISON OF CD4+/CD8+ COUNT OF T-LYMPHOCYTES 
IN HIV PATIENTS OF SEROPOSITIVE AND SERONEGATIVE 
GROUP OF TOXOPLASMOSIS  
 
The CD4+, CD8+ count of T-lymphocytes and CD4+/CD8+ ratio in 
HIV patients of seropositive and seronegative group of toxoplasmosis 
is presented in Table 18. The data were statistically interpreted to 
assess the risk of development of toxoplasmosis as opportunistic 
infection in HIV patients.   
  
The mean CD4+ count of HIV patients in toxoplasmosis 
seropositive male and female group was found to be 111.05 ± 79.96 
and 79.5 ± 27.36 respectively, whereas in seronegative group it was 
218.23 ± 169.38 and 326.57 ± 259.51. Statistically there was 
significant difference between mean CD4+ count in seropositive and 
seronegative group of toxoplasmosis was noticed (at p=0.0001, 
OR=2.09, 95 % CI=1.5-2.9). Similarly significant difference was also 
noticed in the mean CD8+ count and CD4+/CD8+ ratio in the study 
group.   
 69
6. DISCUSSION 
 
The study was conducted to assess the seroprevalence of 
toxoplasmosis in and around Tirunelveli District of Tamil Nadu. 
Hitherto, no systematic study on seroprevalence of toxoplasmosis was 
carried out in this southern most district of Tamil Nadu, which 
necessitates the present study.    
 
6.1  PREPARATION OF T. GONDII TACHYZOITE ANTIGEN 
 
The T. gondii (RH strain) tachyzoite antigen was prepared by  
in vivo mice propagation and in vitro cell culture system and used for 
IFAT and MAT. The above said method was widely accepted for 
preparation of antigen and most of the workers viz., Shirley et al. 
(1982), Mittal et al. (1995) and Singh et al. (1996) also followed the 
same procedure. The tachyzoite soluble antigen (TSA) with protein 
concentration of 0.63 mg/ml was prepared and used for ELISA which 
was in accordance with Loon and Veen (1980), they also used TSA of 
0.61 mg/ml of protein for ELISA.  
 
6.2   EVALUATION OF IgG BASED ASSAYS FOR  
           SERODIAGNOSIS OF TOXOPLASMOSIS 
6.2.1  INDIRECT FLUORESCENT ANTIBODY TEST (IFAT) 
The IgG IFAT was standardized and the cut-off titre for positive 
was arrived at 1:16 and above.  The sensitivity, specificity of IgG IFAT 
in the present study in detecting toxoplasmosis was 80 and 90 per 
cent, respectively. Mittal et al. (1995) considered the titer of 1:64 or 
more were positive whereas, most of recent authors such as   
 70
Sema et al. (2005) and Cavalcante et al. (2006) taken dilutions of 1:16 
and above were as positive for IFAT.  
6.2.2 ENZYME LINKED IMMUNOSORBENT ASSAY 
(ELISA) 
The in-house IgG ELISA for toxoplasmosis was standardised 
and the cutoff value for the ELISA was found to be 0.144 in the 
present study. The sensitivity and specificity of ELISA in detecting 
toxoplasmosis was found to be 90 and 100 per cent, respectively. This 
was in accordance with the findings of Shirley et al. (1982), who 
reported that ELISA was more specific (100 per cent).  
6.2.3  MODIFIED AGGLUTINATION TEST (MAT) 
The formalin killed antigen mixture with 2-mercaptoethanol and 
Evans blue was prepared and used for MAT. In the present study, 
MAT titers of 1:20 and above were considered as positive. The 
sensitivity and specificity of MAT in detecting toxoplasmosis was 80 
and 90 per cent, respectively.  Desmonts and Remington (1980), Singh 
et al. (1996) and Sema et al. (2005) modified the DAT and reported 
that antibody titers of 1:20 or more were taken as positive.  
6.3.  COMPARATIVE EVALUATION OF THREE IgG BASED ASSAYS  
 
In the current study, among the three assays, the ELISA was 
found to be highly specific (100 per cent) and sensitive (90 per cent) 
for detecting toxoplasmosis. This was in accordance with the findings 
of Shirley et al. (1982) who reported that the ELISA was more specific, 
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than the IFA. However, the IFA was more reproducible and more rapid 
than the ELISA.  
 
6.4.  SEROPREVALENCE OF TOXOPLASMOSIS  
In the present study, out of 350 patients tested, 41 (11.71 per 
cent), 46 (13.14 per cent) and 39 (11.41 per cent) patients were found 
to be seropositive for toxoplasmosis by IgG IFAT, ELISA and MAT, 
respectively. The overall seroprevalence of toxoplasmosis in and 
around Tirunelveli District of Tamil Nadu was arrived as 13.14  
per cent based on IgG ELISA.  
 
In India, the exact seroprevalence of toxoplasmosis was not 
known. However, using various diagnostic tests, the prevalence has 
been reported to be as low as 1 per cent and as high as 80 per cent in 
adults (Singh, 2003). Until recently the prevalence of T. gondii in the 
general population of India was considered to be low when compared 
with Western countries (Bowerman, 1991 and Mittal et al., 1995). This 
may be partially true, but the data are based on convenience samples 
obtained from patients admitted to hospitals in big cities. The type of 
serological tests used and the titres taken as evidence of infection are 
also important factors. However, only studies during 1990 indicated 
that the prevalence may be a lot higher than previously considered 
(Singh and Nautiyal, 1991 and Singh et al., 1994).  
 
Bhatia et al. (1974) reported only 12 per cent seropositivity for 
toxoplasmosis in South India, whereas, Mittal et al. (1990), revealed 
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an overall seroprevalence of only 1 per cent from Delhi. Singh and 
Nautiyal (1991) noted a high prevalence (75 per cent) of T. gondii in 
Almora, North India in women of child bearing age, ever reported 
earlier from any part of India. Singh (2002) reported the 
seroprevalence study, with highest prevalence of 77 per cent from 
North India.  
 
In this study, among the immunocompetant group of 175 
patients, 19 patients (10.86 per cent) had antibodies to toxoplasmosis 
whereas, in immunodeficient group of 175 patients, 27 patients (15.43 
per cent) had antibodies for toxoplasmosis. Meisheri et al. (1997) 
reported the overall seroprevalence from Bombay was 30.9 per cent 
(51/165) in the immunocompetent adult and in immunodeficient 
patients it was 67.8 per cent.  
 
Out of 135 pregnant women tested, 13 (9.63 per cent) were 
seropositive in the current study. The prevalence of toxoplasmosis in 
Indian pregnant women was variably reported (Singh, 2003). 
Chakraborty et al. (1995) stated that 7.1 per cent prevalence of 
toxoplasmosis in pregnant women from Calcutta whereas, Singh and 
Pandit (2004) reported 45 per cent of prevalence in pregnant women 
by using IgG Avidity ELISA test. 
 
However, Singh, (2003) quoted that the knowledge about this 
infection, diagnosis and interpretation of the test results in pregnant 
women was a major problem in the Indian context. Though, 
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Toxoplasma infection does not cause repeated foetal losses, this is the 
most common indication for investigation of toxoplasmosis in India. In 
this present study also only 3 out of 19 (15. 79 Per cent) cases with 
bad obstetric history were seropositive for toxoplasmosis. So BOH was 
not alone taken as criteria for routine screening of toxoplasmosis.  
 
In the present study, among the 20 cases of lymphadenopathy, 
only 3 (15 per cent) were seropositive. Of the 20 ocular cases tested, 
only 3 (15 per cent) were seropositive. Recently, Manikandan et al., 
(2006) reported an outbreak of ocular toxoplasmosis in Coimbatore, 
Tamil Nadu, about 71.5 per cent of particular area were had high 
titres of both IgM and IgG antibodies which was an acute acquired 
type through municipal water contamination.  
 
Present study revealed, 15 per cent seropositive among the  HIV 
positive individuals tested by IgG ELISA and out of 15 cases of 
malignancy, only 3 (20 per cent) were seropositive. Meisheri et al. 
(1997) from Bombay reported that the seroprevalence rate of 
toxoplasmosis was 67.8 per cent in HIV patients.   
 
In this study, the significant difference was noticed between IgG 
IFA and ELISA at p<0.05 whereas, the significant difference at p<0.01 
was found between MAT and IgG ELISA in detecting toxoplasmosis. 
Statistically the testing efficiency of IgG ELISA for detecting 
toxoplasmosis was higher than the other two tests.  Similar results 
were observed by Pappas et al. (1986) and Shirley et al. (1982).  
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6.5.  ANALYSIS OF VARIOUS SOCIO DEMOGRAPHIC RISK 
FACTORS  
 
In this study, there was a significant difference between sex of 
the study population and drinking water source. Seroprevalence was 
increased in the male than the female and with river water 
consumption other than bore water. There was significant difference 
between 21-30 years group than the other.  About 15 per cent of 
patients belonging to rural area of Tirunelveli District had anti-
Toxoplasma antibodies.   
 
As in the study of Bobic et al. (1998) and Sema et al. (2005) that 
have found that prevalence increases as the age increases, as the age 
effect was observed in the current study. The reason might be 
increasing risk of exposure with age.  
 
In the current study, no statistical meaningful difference was 
observed between urban and rural areas for toxoplasmosis 
seroprevalence in Tirunelveli District. Baril et al. (1999) have found 
similar results with the current study; however, Ades et al. (1993) 
have found higher seroprevalences of toxoplasmosis in urban areas.  
 
Sema et al. (2005) also reported higher prevalence of 
toxoplasmosis in municipal network water users which was well 
correlated with the current study. Frequent consumption and type of 
meat in non-vegetarian group were identified as the principle risk 
factor in several recent studies of T. gondii infections in humans 
(Bobic et al., 1998 and Sema et al., 2005). No relation was observed 
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between seroprevalence of vegetarian and non-vegetarian in the 
current study and most of the study population (99 .5 per cent) was 
belonging to non-vegetarian. 
The association of cats and human toxoplasmosis was difficult 
to assess by epidemiological surveys because soil, not the cats, is the 
main culprit. In the current study, the number of cat owners was just 
a few and no relation was detected which was similar to the findings 
of Sema et al. (2005).  
6.6 COMPARISON OF CD4+/CD8+ COUNT OF T-LYMPHOCYTES 
IN HIV PATIENTS  
 
 In the current study, the mean CD4+ count/µl of HIV patients of 
seropositive (Male 111.05  and Female 79.5) and seronegative (Male 
218.23 and Female 326.5) group of toxoplasmosis was interpreted to 
assess the risk of development of toxoplasmosis as opportunistic 
infection. The similar observation of CD4+ count of 135/µl was 
observed in HIV patients by Kumarasamy et al. (2003).   
 
As per the observation made by Kasper (2005), HIV Patients 
with CD4+ T cell counts <100/µl may develop highest risk for 
toxoplasmosis. HIV Patients with IgG antibody to Toxoplasma should 
receive prophylaxis for toxoplasmosis with Trimethoprim/ 
Sulfamethoxazole. Those who are seronegative should be counseled 
about ways to minimize the risk of primary infection including 
avoiding the consumption of undercooked meat and careful hand 
washing after contact with soil or changing the cat litter box.  
7. SUMMARY 
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 The present study was conducted at Tirunelveli Medical College 
Hospital, Palayamkottai, Tirunelveli District, Tamil Nadu from May’ 
2006 to October’ 2007 to assess the seroprevalence of toxoplasmosis 
in and around Tirunelveli using in-house IgG based assays viz., IFAT, 
ELISA and MAT.  
 
# A total of 350 peripheral blood samples for this study were 
collected from 175 immunodeficient and 175 immunocompetent 
patients.  
# The Toxoplasma gondii (RH strain) tachyzoite antigen was 
prepared by in vivo mice propagation and in vitro cell culture 
system in MDCK fibroblast cell line.   
# Formalin–killed T. gondii tachyzoite antigen for IFAT and MAT 
and the tachyzoite soluble antigen (TSA) for ELISA were 
prepared. 
# The IgG IFAT, ELISA and MAT were standardized and the cut-off 
titre for IFAT positive was arrived at 1:16 and above. The cutoff 
value for the IgG ELISA was found to be 0.144.  MAT antibody 
titers of 1:20 or more were taken as significant for reporting 
positive results.   
# Out of 350 patients tested, 41 (11.71 per cent), 46 (13.14  
per cent) and 39 (11.41 per cent) patients were found to be 
seropositive for toxoplasmosis by IgG IFAT, ELISA and MAT 
respectively.  
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# Among the three assays, IgG ELISA was found to be highly 
sensitive (90 per cent) and specific (100 per cent) in detecting 
toxoplasmosis, whereas the IgG IFAT and MAT were equal in 
sensitivity (80 per cent) and specificity (90 per cent). 
# Statistically the testing efficiency of IgG ELISA in detecting 
toxoplasmosis was higher (p<0.05) than the other two tests.  
# The overall seroprevalence of toxoplasmosis in and around 
Tirunelveli District of Tamil Nadu was arrived as 13.14 (46/350) 
per cent based on IgG ELISA. Seroprevalence of toxoplasmosis 
in immunocompromised and immunocompetent patients were 
of 15.43 (27/175) and 10.86 (19/175) per cent, respectively.  
# The seroprevalence of toxoplasmosis in pregnant women was 
found to be 9.63 (13/135) per cent. Only 3 out of 19 (15. 79  
per cent) cases with bad obstetric history (BOH) were positive 
for toxoplasmosis.  
# There was a significant difference between sex of the study 
population and drinking water source. Seroprevalence was 
increased in the male (19.12 %, p=0.0075, OR=2.316, 95 % 
CI=1.2362-4.3405) than the female and with river water 
consumption other than bore water (12.5 %, p=0.0483, 
OR=0.857, 95 % CI=0.1853-3.4641).  
# Among the different age groups (<20 – 80 years) studied, there 
was significant difference between 21-30 years group than the 
others (p=0.02, OR=3.46, 95 % CI=1.08 -11).  
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# Out of 208 patients belonging to rural area and 56 cases from 
urban area of Tirunelveli District tested, 33 (15.71 per cent) and 
9 (10.71 per cent) were had anti-Toxoplasma antibodies, 
respectively.   
# The seroprevalence of toxoplasmosis in HIV patients was found 
to be 15 per cent (24/160). Male HIV patients with multiple 
heterosexual behaviour were observed to be having higher 
seropositivity for toxoplasmosis (25.58 per cent) than single 
sexual behaviour.  
# The mean CD4+ count of HIV patients of seropositive (Male - 
111.05 ± 79.96 and Female- 79.5 ± 27.36) and seronegative 
(Male- 218.23 ± 169.38 and Female- 326.5 ± 259.51) group of 
toxoplasmosis was statistically interpreted to assess the risk of 
development of toxoplasmosis as opportunistic infection.  
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8. CONCLUSION 
  
# The study has highlighted an overall 13.14 per cent of seroprevalence of 
toxoplasmosis, which constitutes 15.43 per cent in immunocompromised 
and 10.86 per cent in immunocompetent patients in and around 
Tirunelveli District of Tamil Nadu. The study underlines the importance of 
screening of this parasite especially in the immunocompromised patients. 
# The seroprevalence of toxoplasmosis in pregnant women was about 10  
per cent, which necessitates initial screening for IgG antibodies and then 
a paired sera sample after 3 weeks should be tested for rise in titer. 
Thereafter, the IgM antibodies should be tested to exclude the recent 
infection. All seropositive women who seroconvert during pregnancy 
should be followed and their amniotic fluid / foetus should be screened by 
PCR and Ultrasound, respectively.  
# Only 3 out of 19 (15. 79 Per cent) cases with bad obstetric history (BOH) 
were positive for toxoplasmosis, so BOH is not alone taken as criteria for 
routine screening of toxoplasmosis.  
# The in-house IgG ELISA was found to be 90 per cent sensitivity and 100 
per cent specificity. IFAT and MAT were equal in sensitivity and 
specificity. Since in-house assays were cost effective and can be used for 
routine serological screening.  
# Fifteen per cent of HIV patients were found to have anti-Toxoplasma 
antibodies, so routine screening for serology for toxoplasmosis should be 
done especially when the CD4+ count was less than 200/µl, who may 
have a risk for development of toxoplasmosis as opportunistic infection.  
 
Table 1 
Historical landmarks of Toxoplasma gondii 
(Dubey, 1993) 
 
Contributors and year Contribution  
Charles Nicolle and Louis 
Manceaux (1908) 
Discovered in gundi 
Alfonso Splendore (1908) Discovered in rabbit 
Mello (1910) Described in domestic animal, 
dog 
Janku (1923) Identified in human eye 
Wolf, Cowen and Paige (1939) Congenital transmission 
documented 
Pinkerton and Weinman (1940) Fatal disease described in 
adult human 
Sabin (1942) Disease characterised in man 
Sabin and Feldman (1948) Dye test described 
Siim (1952) Glandular toxoplasmosis in 
man 
Weinman and Chandler (1954) Suggested carnivores 
transmission  
Hartely and Marshall  (1957) Abortion in sheep recognised 
Beverley (1959)  Repeated congenital 
transmission   
Jacobs et al. (1960) Tissue cysts characterised 
William McPhee Hutchison (1965) Faecal transmission 
recognised; nematode egg 
suspected for transmission 
Hutchison et al.  (1969, 1970, 
1971); Jack Frenkel et al. (1970); 
Dubey et al. (1970); Sheffield and 
Melton (1970), Overdulve (1970) 
Described the coccidian phase 
Jack Frenkel et al. (1970);  
Miller et al. (1972) 
Definitive and intermediate 
host defined 
Dubey and Frenkel (1972) Five T. gondii types described 
from feline intestinal 
epithelium 
Wallace (1969); Munday (1972) Confirmed the epidemiological 
role of cats from studies on 
remote islands    
 
 
Table 2 
 
Taxonomic classification of  
Toxoplasma gondii  Nicolle and Manceaux, 1908 
 
Kingdom 
Subkingdom 
Phylum 
Class 
Subclass 
Order 
Suborder 
Family 
Subfamily 
Genus 
Species 
Protista  
Protozoa  
Apicomplexa  
Sporozoasida  
Coccidiasina 
Eucoccidiorida  
Eimeriorina 
Sarcocystidae  
Toxoplasmatinae 
Toxoplasma  
T. gondii 
 
Table - 3 
 
Report on seroprevalence of toxoplasmosis in  
human beings in India 
(Mahajan, 1997) 
 
 
Sl. 
No. 
 
Area 
 
Number 
tested 
 
Test 
 
Per cent
positive 
 
 
Author(s) 
and year 
1. Bombay 141 (Veg) 
246 (Non-veg)
DT 21.0 
18.0 
Rawal (1954) 
2. Delhi 135  (Veg) 
400 (Non-veg)
CFT 1.5 
4.5 
Kalra (1957) 
3. Delhi 60 DT 16.7 Prakash and 
Choudhary 
(1969) 
4. Hissar 185 IHA≥1:16 18.9 Bhardwaj 
(1974)             
5. South India  130 IHA≥1:128 12.0 Bhatia et al. 
(1974) 
6. Chandigarh  641 IHA≥1:128 8.1 Mahajan et al.
(1976) 
7. Delhi 116 IHA≥1:16 5.2 ICMR (1976) 
8. Rotak 141 IHA≥1:16 4.2 Chugh et al. 
(1978) 
9. Kashmir 100 ELISA 
≥1:128 
1.0 Thokar et al. 
(1988) 
10 Kumaon  200 IHA≥1:18 77.0 Singh and 
Nauttiyal 
(1991) 
 
Table – 4 
 
EVALUATION OF IgG IFAT FOR DETECTING TOXOPLASMOSIS 
 
 
 
True Positive 
(a) 
 
8 
 
 
False Positive 
(b) 
 
1 
 
False Negative 
(c) 
 
2 
 
True Negative 
(d) 
 
9 
 
 
           a 
 Sensitivity of IgG IFAT  =  ------   X  100  =  80 % 
                  a + c 
 
            d 
 Specificity of IgG IFAT  =   ------  X  100  =  90.0 % 
                  b + d 
 
           a 
 Positive predictive   =  ------   X  100  =  88.89 % 
 value of IgG IFAT      a + b 
 
           d 
 Negative predictive   =  ------   X  100  =  81.81 % 
 value of IgG IFAT       c + d 
 
Table – 5 
 
EVALUATION OF IgG ELISA FOR DETECTING TOXOPLASMOSIS 
 
 
 
True Positive 
(a) 
 
9 
 
 
False Positive 
(b) 
 
0 
 
False Negative 
(c) 
 
1 
 
True Negative 
(d) 
 
10 
 
 
           a 
 Sensitivity of IgG ELISA  =  ------   X  100  =  90.0 % 
                  a + c 
 
            d 
 Specificity of IgG ELISA  =   ------  X  100  =  100 % 
                  b + d 
 
           a 
 Positive predictive   =  ------   X  100  =  100 % 
 value of IgG ELISA     a + b 
 
           d 
 Negative predictive   =  ------   X  100  =  90.9 % 
 value of IgG ELISA      c + d 
 
Table – 6 
 
EVALUATION OF MAT FOR DETECTING TOXOPLASMOSIS 
 
 
 
True Positive 
(a) 
 
8 
 
 
False Positive 
(b) 
 
1 
 
False Negative 
(c) 
 
2 
 
True Negative 
(d) 
 
9 
 
 
           a 
 Sensitivity of MAT   =  ------   X  100  =  80.0 % 
                  a + c 
 
            d 
 Specificity of MAT  =   ------  X  100  =  90.0 % 
                  b + d 
 
           a 
 Positive predictive   =  ------   X  100  =  88.89 % 
 value of MAT      a + b 
 
           d 
 Negative predictive   =  ------   X  100  =  81.81 % 
 value of MAT       c + d 
 
Table – 7 
 
 
EVALUATION OF THREE IgG BASED ASSAYS (IFAT, MAT & ELISA) 
FOR ITS SENSITIVITY AND SPECIFICITY  
FOR DETECTING TOXOPLASMOSIS 
 
 
Sl. 
No. Category IFAT MAT ELISA 
1. 
 
Sensitivity (%) 
 
80.0 80.0 90.0 
2. 
 
Specificity (%) 
 
90.0 90.0 100 
3. 
 
Positive predictive 
value (%) 
 
88.89 88.89 100 
4. 
 
Negative predictive  
value (%) 
 
81.81 81.81 90.9 
Table – 8 
 
SEROPREVALENCE OF TOXOPLASMOSIS BY IgG IFAT 
 
 
Sl. 
No. 
Category of 
patients 
Number of 
patients 
examined 
Number 
of 
patients 
positive  
Per cent 
positive 
(%)  
Mean titre 
with ± SE 
and Range 
of positive 
patients 
Immnocompetant 
 
1. Pregnant women  
 
135 
 
13 
 
9.63 
 
 
51.69 ± 74.23 
(1:16 – 1:256) 
 
2. Lymphadenopathy 20 3 15.0 
 
26.6 ± 9.23 
(1:16-1:32) 
 
3. Ocular 20 3 15.0 
 
58.67 ± 60.57 
(1:16-1:128) 
 
Immunodeficient 
 
4. HIV positive 
individuals 
 
160 
 
19 
 
11.88 
 
 
45.47 ± 61.33 
(1:16-1:256) 
 
5. Malignancy 15 3 20.0 
 
26.6 ± 9.23 
(1:16-1:32) 
 
 TOTAL 350 41 11.71 
 
43.32 ± 58.7 
(1:16-1:256) 
 
 
 Table – 9 
 
SEROPREVALENCE OF TOXOPLASMOSIS BY IgG ELISA  
 
Sl. 
No. 
Category of 
patients 
Number of 
patients 
examined 
Number 
of 
patients 
positive  
Per cent 
positive 
(%)  
Mean OD 
value with ± 
SE and 
Range of 
positive 
patients 
Immnocompetant 
 
1. Pregnant women 
 
135 
 
13 
 
9.63 
 
 
0.191 ± 0.069 
(0.148 – 0.357) 
 
2. Lymphadenopathy 20 3 15.0 
 
0.162 ± 0.029 
(0.144 – 0.196) 
 
3. Ocular 20 3 15.0 
 
0.179 ± 0.043 
(0.147 – 0.228) 
 
Immunodeficient 
 
4. 
HIV positive 
individuals 
 
 
160 
 
24 
 
15.0 
 
0.212 ± 0.079 
(0.146 – 0.444) 
5. Malignancy 15 3 20.0 
 
0.173 ± 0.025 
(0.146 – 0.196) 
 
 
 
TOTAL 
 
350 
 
46 
 
13.14 
 
 
0.2 ± 0.073 
(0.144 – 0.444) 
 
 
Table – 10 
 
SEROPREVALENCE OF TOXOPLASMOSIS BY MAT   
 
Sl. 
No. 
Category of 
patients 
Number of 
patients 
examined 
Number 
of 
patients 
positive  
Per cent 
positive 
(%)  
Mean titre 
with ± SE 
and Range 
of positive 
patients 
Immnocompetant  
 
1. 
 
Pregnant women  
 
135 
 
12 
 
8.89 
 
 
55 ± 63.32 
(1:20 – 1:160) 
 
 
2. 
 
Lymphadenopathy 
20 3 15.0 
 
33.33 ± 11.54 
(1:20-1:40) 
 
 
3. 
 
Ocular 
20 3 15.0 
 
73.33 ± 75.71 
(1:20-1:160) 
 
Immunodeficient 
 
4. HIV positive 
individuals 
 
160 
 
18 
 
11.25 
 
 
50 ± 51.44 
(1:20-1:160) 
 
5. Malignancy 15 3 20.0 
 
33.33 ± 11.54 
(1:20-1:40) 
 
  
TOTAL 350 39 
 
11.14 
 
 
53.85 ± 55.28 
(1:20-1:160) 
 
 
Table – 11 
COMPARISON OF THREE IgG BASED ASSAYS (IFAT, MAT & ELISA) 
FOR DETECTING TOXOPLASMOSIS 
Number of positive patients and 
per cent (%) positive  
Sl. 
No. 
Category of 
patients 
Number of 
patients 
examined IFAT MAT ELISA 
Immnocompetant  
1. Pregnant women  
 
135 
 
13  
(9.63 %) 
 
12 
(8.89 %) 
 
13  
(9.63 %) 
2. Lymphadenopathy 20 3  
(15 %) 
3  
(15 %) 
3  
(15 %) 
3. Ocular 20 3  
(15 %) 
3  
(15 %) 
3  
(15 %) 
Immunodeficient  
4. HIV positive 
individuals 
  
160   
 
19  
(11.88 %) 
 
18  
(11.25%) 
 
24  
(15 %) 
5. Malignancy 15 3  
(20 %) 
3  
(20 %) 
3  
(20 %) 
  
TOTAL 
 
350 
 
41  
(11.71 %) 
 
39 
(11.14%) 
 
46  
(13.14 %) 
Table – 12 
 
COMPARISON OF TESTING EFFICIENCY OF THREE IgG BASED 
ASSAYS (IFAT, MAT & ELISA) BY McNEMAR’S TEST  
Tabulated 
value Sl. 
No. 
Test  
(n = 350,  
degree of freedom 
=349) 
Calculated  
z value  
at 
0.01 
level 
at 
0.05 
level 
Remark 
(Test of 
significance) 
1. IFA with MAT 0.357 NS 2.58 1.96 Not-significant 
2. IFA with ELISA 2.232 * 2.58 1.96 
*Significant at 
p<0.05 
3. ELISA with MAT 2.646 ** 2.58 1.96 
**Significant at 
p<0.01 
 
Table – 13 
SEROPREVALENCE OF TOXOPLASMOSIS IN PREGNANT WOMEN 
a. Based on gravid 
Sl. 
No. 
Gravida No. of 
patients 
tested 
No. of 
patients 
positive for 
IgG 
Percentage 
(%) 
1. Primi  52 5 9.62 
2. G2 56 4 7.14 
3. G3 21 2 9.52 
4. G4 3 2 66.67 
5. G5 3 0 0 
 Total 135 13 9.63 
 
b. Based on trimester of pregnancy 
Sl. 
No. 
Trimester of 
pregnancy 
No. of 
patients 
tested 
No. of 
patients 
positive for 
IgG 
Percentage 
(%) 
1. I Trimester 11 1 9.1 
2. II Trimester 44 6 13.6 
3. III Trimester 80 6 7.5 
 Total 135 13 9.63 
c. Based on bad obstetric history (Abortion/premature delivery) 
Sl. 
No 
Trimester of 
pregnancy 
No. of patients 
with bad 
obstetric history 
(Abortion/PMD) 
No. of 
patients 
positive for 
IgG 
 
Percentage 
(%) 
1. I Trimester 3 1 33.34 
2. II Trimester 8 - - 
3. III Trimester 8 2 25.0 
 Total 19 3 15.79 
 Table – 14 
 
 
ANALYSIS OF SOCIO DEMOGRAPHIC RISK FACTORS ASSOCIATED 
WITH THE SEROPREVALENCE OF TOXOPLASMOSIS  
                                                                                     
 
Sl. 
No. 
 
Risk factors 
No. of 
patients 
tested 
(n = 350) 
No. of 
patients 
positive 
for IgG 
Perce
ntage 
(%) 
 
Odds 
ratio 
 
95 % CI 
 
p  
value 
(χ2 test) 
# 
 
1. Age 
a. >20 years 
b. <20 years 
 
19 
331 
 
3 
43 
 
15.79 
12.99 
 
 
1.255 
 
0.3512- 
4.4901 
 
0.7255 
2. Gender 
a. Male 
b. Female 
 
136 
214 
 
26 
20 
 
19.12 
9.35 
 
2.316 
 
1.2362- 
4.3405 
 
 
0.0075
* 
3. Residence 
a. Rural 
b. Urban 
 
278 
72 
 
39 
7 
 
14.02 
9.72 
 
 
1.515 
 
0.6476- 
3.5450 
 
0.3351 
4. Water source 
a. River water 
b. Bore water 
 
336 
14 
 
42 
2 
 
12.5 
14.29 
 
 
0.857 
 
0.1853- 
3.4641 
 
0.0483
* 
5. Diet 
a. Vegetarian 
b. Non-vegetarian 
 
2 
348 
 
1 
45 
 
50.0 
12.93 
 
 
6.73 
 
0.4138- 
109.569 
 
0.1218 
6 Animal contact 
a. Yes 
b. No 
 
 40 
310 
 
8 
38 
 
20.0 
12.26 
 
 
1.789 
 
0.768- 
4.1695 
 
0.1726 
 
# Results of χ2 test and Fisher’s Exact test by p value of < 0.05 as 
significant difference* 
Table – 15 
 
SEROPREVALENCE OF TOXOPLASMOSIS  
ACCORDING TO AGE AND SEX  
                                      (n= 350)     
                                           
No. of 
patients  
No. of patients 
positive for 
IgG 
Percentage 
(%) of 
positivity 
 
Sl. 
No. 
 
Age 
 
Male Female Male Female Male Female
 
Odds 
ratio 
 
95 % 
CI 
p  
value 
(χ2 
test) 
# 
1. 
<20  
years 6 7 2 1 33.34 14.29 3 
 
0.19- 
45.2 
 
0.41 
2. 21 – 30 
years 
 
19 150 5 14 26.32 9.33 3.46 1.08- 11.0 
0.02 
* 
3. 31 – 40 
years 
 
54 38 10 4 18.19 10.52 1.93 0.55 -6.69 0.29 
4. 41 – 50 
years 
 
29 6 4 1 13.79 16.67 0.8 0.07- 8.75 0.85 
5. 51 – 60 
years 
 
14 8 3 - 21.43 - 5.67 0.47- 6.73 0.15 
6. 61 – 70 
years 
 
12 3 2 - 16.67 - 3.84 0.01-1.40 0.44 
7. 71 – 80 
years 
 
2 2 - - - - - - - 
  
Total 
 
136 
 
214 
 
26 
 
20 
 
19.12 
 
9.34 
 
2.31 
 
1.2 
- 
4.3 
 
 
0.007 
 
# Results of χ2 test and Fisher’s Exact test by p value of < 0.05 as 
significant difference 
 Table – 16 
 
 
SEROPREVALENCE OF TOXOPLASMOSIS IN DIFFERENT REGIONS 
IN SOUTHERN DISTRICTS OF TAMIL NADU    
                                                                                     
 
Sl. 
No.
 
Region 
 
No. of 
patients 
tested 
 
 
No. of 
patients 
positive 
for IgG 
 
 
Perce
ntage 
(%) 
 
Odds 
ratio 
 
95 % 
CI 
 
p  
value 
(χ2 
test) # 
 
1. Tirunelveli 
a. Urban 
b. Rural 
 
 
56 
208 
 
6 
33 
 
10.71 
15.87 
 
0.636 
 
0.252 - 
1.6048 
 
0.3349 
2. Tuticorin 
a. Urban 
b. Rural 
 
 
12 
65 
 
1 
5 
 
8.33 
7.69 
 
1.09 
 
0.116- 
10.26 
 
0.0161
* 
3. Kanyakumari 
a. Urban 
b. Rural 
 
 
4 
5 
 
0 
1 
 
0 
20 
 
0.165 
 
0.003- 
8.5371 
 
0.3248 
 
 
TOTAL 350 46 13.14    
 
# Results of χ2 test and Fisher’s Exact test by p value of < 0.05 as 
significant difference * 
Table – 17 
 
 
RISK FACTORS IN HIV PATIENTS WITH SEROPOSITIVE AND 
SERONEGATIVE GROUP OF TOXOPLASMOSIS  
 
 
No. of patients 
tested 
 
No. of patients 
positive for 
IgG 
 
 
Percentage 
(%) 
 
Sl. 
No. 
 
Risk factor 
Male Female Male Female Male Female 
1. Sexual 
behaviour 
a. Single  
b. Multiple 
 
 
54 
43 
 
 
55 
2 
 
 
8 
11 
 
 
3 
1 
 
 
14.81 
25.58 
 
 
5.45 
50.0 
2. Vertical 
transmission 
2 4 1 - 50.0 - 
3. Blood 
transfusion 
4 - - - - - 
4. I/V drug abuser 1 - - - - - 
5. Needle 
injury/surgery 
4 6 - - - - 
6. Stages of HIV 
infection 
1. Stage I 
2. Stage II 
3. Stage III 
4. Stage IV 
 
 
35 
10 
48 
6 
 
 
 
42 
1 
15 
3 
 
 
7 
2 
11 
- 
 
 
3 
- 
1 
- 
 
 
20.0 
10.0 
22.91 
0 
 
 
7.14 
- 
9.09 
- 
 
Table – 18 
 
COMPARISON OF CD4+ and CD8+ COUNT [Mean count (cells/µl) ± SE] 
IN HIV PATIENTS WITH SEROPOSITIVE AND SERONEGATIVE 
GROUP OF TOXOPLASMOSIS  
                                                                                     
Seropositive 
toxoplasmosis  
group  
 
Seronegative 
toxoplasmosis  
group  
 
 
Sl. 
No. 
 
Category 
Mean 
count 
(cells/µl) 
Male Female Male Female 
 
Odds 
ratio 
 
95 
% 
CI 
 
p 
value 
(χ2 
test) # 
1. CD4+  
 
111.05 
± 
79.96 
 
 
79.5 
± 
27.36 
 
 
218.23 
± 
169.38 
 
 
326.57 
± 
259.51 
 
 
 
2.09 
 
 
1.5- 
2.9 
 
 
0.0001 
* 
2. CD8+  
621.8 
± 
379.88 
 
514 
± 
183.48 
 
 
986.17 
± 
493.86 
 
 
1062.63 
± 
494.21 
 
 
 
1.30 
 
 
1.1- 
1.5 
 
 
0.0004 
* 
3. CD4+/CD8+  
 
0.18 
± 
0.09 
 
0.16 
± 
0.01 
 
0.27 
± 
0.16 
 
 
0.32 
± 
0.24 
 
 
 
1.33 
 
0.0- 
0.63 
 
0.0349 
* 
# Results of χ2 test and Fisher’s Exact test by p value of < 0.05 as 
significant difference * 
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 ANNEXURE  I 
RECIPE FOR BUFFERS AND SOLUTIONS USED 
Phosphate buffered saline (PBS) without Ca++ and Mg++ (1x, pH 7.2)  
 
Sodium chloride      8.00 g  
Potassium chloride     0.20 g  
Disodium hydrogen orthophosphate dihydrate 1.41 g  
Potassium dihydrogen orthophosphate  0.20 g  
Distilled water to make (adjust pH to 7.2)  1000 ml  
 
PBS – T  
 
PBS 10X solution      100 ml 
Tween – 20       0.5 ml 
Triple glass distilled water to     1 litre 
 
pH adjusted to 7.2  
   
Buffered glycerol (pH 9.0, for IFAT)  
Phosphate buffer      1 volume 
[Na2HPO4 - 284g /10ml H2O (pH 9.0)]  
Glycerol         9 volumes  
 
Carbonate-bicarbonate buffer for ELISA 
Sodium carbonate      1.59 g 
Sodium bicarbonate      2.93 g 
Distilled water to make up to      1   litre 
Adjust the pH to      9.6 
 
Skimmed Milk 1 per cent for ELISA 
 
Skimmed Milk powder   1g                 
PBS –T to     100 ml 
 
Hydrofluric acid 0.1 M for ELISA 
 
Hydrofluric acid (Concentrated)  3.5 ml 
Triple glass distilled water to   1 litre 
 
Borate buffer for MAT 
 
Sodium chloride    7.01 g 
Boric acid     3.09 g 
Sodium azide    2 g 
1N NaOH     24 ml 
Deionised water to make up to 1 litre 
Adjust the pH to   8.95 
 
 
Working antigen diluting buffer for MAT 
  
Bovine Serum Albumin  0.4 g 
Borate buffer    100 ml 
 
 
Antigen mixture for the MAT 
 
Antigen diluting buffer   2.5 ml  
2-mercaptoethanol   35 µl 
Evans blue dye solution  50 µl 
Formalin killed antigen   0.15 ml 
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ANNEXURE  II 
 
     DATA SHEET FOR COLLECTION OF   
SOCIO-DEMOGRAPHIC, CLINICAL AND BEHAVIORAL DATA 
FOR P.G. DISSERTATION WORK ON  
 
“Evaluation of different serodiagnostic methods of Toxoplasmosis 
in pregnant women and immunodeficient patients” 
 
I. GENERAL INFORMATION 
 
Name    :       Age :  Sex:  M / F 
 
Address :      Occupation : 
 
 
Referred by :                UNIT                  WARD             OP/IP No. : 
 
 
 
Income :     Urban/ Rural / Migrant  
 
Educational status :   Occupation of the partner: 
 
Marrital status :  Married / Unmarried  Duration : 
 
 
II. EPIDEMIOLOGICAL RISK FACTOR ASSESSMENT  
 
 
Food habits  :  Vegetarian  /  Non-vegetarian 
 
Type of food :  Salad / greens / Meat type Cooked / half cooked  
 
Drinking water source : Well / River /  others 
 
Close contact with cat : Owner of cat / access to cat : 
 
Close contact / access with domestic animal / chicken : 
 
Whether consumed raw goat milk : 
 
Habits : Alcohol / Smoking/ Tobacco / Drugs  
 
Organ transplantation : 
Family H/o :  
 
Specific Medical history : 
Lab No. : 
 2
III. ANTENATAL  RISK ASSESSMENT : 
 
If married women 
Pregnant / Non pregnant/  
 
Menstrual history : 
 
LMP :     Gravida: 
 
EDD :     Para : 
 
CEDD:     Live : 
 
Abortion / still birth   MTP : 
 
LSCS:     LCB : 
 
Previous obstetric history : 
 
 
Status of baby born  : 
 
Illness of present or previous baby : 
 
H/o Congenital infection (maternal infection acquired during 
pregnancy) 
 
H/o Mother to foetus transmission / placental transmission 
 
 
IV. HIV RISK ASSESSMENT : 
 
 
Height :   Weight : 
 
Sex behaviour : Hetero/Homo/ Bisexual/ No sex 
 
Partner :         Single  / Multiple 
 
Blood transfusion :   Vertical transmission : 
 
I/V drug user:     Needle Injury : 
 
Injection :    Hospital acquired injury : 
 
Others (specify) : 
 
 
 
 3
V. CLINICAL ASSESSMENT : 
 
History of Previous clinical illness with duration : 
 
 
 
 
Present Clinical symptoms :   
 
Fever  
 
Lymphadenopathy / lymphadenitis 
 
Ocular lesions / chorioretinitis 
 
Neurological symptoms / Encephalitis 
 
Haematological malignancy  
 
Myocarditis  
 
Polymyositis 
 
Others (specify if any) 
 
 
VI. CLINICAL DIAGNOSIS :  
  
 Tentative clinical diagnosis   : 
 
 Concurrent infections (if any)  : 
 
 
VII. TREATMENT / ADVISE  GIVEN IN THE UNIT: 
 
 
 
 
 
 
 
 
VIII. FOLLOW UP OF A PATIENT (if needed) : 
 4
IX. LAB INVESTIGATIONS 
 
SAMPLES COLLECTED :  
 
BLOOD for Serum / Peripheral blood for flowcytometry 
 
RESULTS OF HIV ANTIBODY TEST 
 
Name of the test :  Qualitative MICROELISA                                               
 
Result  : Seropositive / Seronegative 
 
RESULTS OF FLOWCYTOMETRY 
CD4+, count :           cells/µl 
CD8+, count :    cells/µl 
CD4+/CD8+ ratio : 
 
RESULTS OF CONCURRENT INFECTIONS (if any) 
 
 
 
RESULTS OF specific blood parameters (if any) 
 
 
 
RESULTS OF ultra scan /CT scan/ MRI (if any) 
 
 
RESULTS OF SERODIAGNOSIS OF TOXOPLAMOSIS 
 
Date of the test     :  
 
 MAT IgG IFAT 
 
IgG ELISA 
 
 
RESULT 
 
   
 
TITRE 
 
   
Follow up 
Titre (if any)    
 
 
Date:           
Signature : 
 
